PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"35429482","Tuberculous meningitis: progress and remaining questions","Huynh J, Donovan J, Phu NH, Nghia HDT, Thuong NTT, Thwaites GE.","Lancet Neurol. 2022 May;21(5):450-464. doi: 10.1016/S1474-4422(21)00435-X.","Huynh J","Lancet Neurol","2022","2022/04/16","","","10.1016/S1474-4422(21)00435-X"
"35220372","Drug-resistant tuberculosis: advances in diagnosis and management","Günther G, Ruswa N, Keller PM.","Curr Opin Pulm Med. 2022 May 1;28(3):211-217. doi: 10.1097/MCP.0000000000000866. Epub 2022 Feb 25.","Günther G","Curr Opin Pulm Med","2022","2022/02/27","PMC9415219","","10.1097/MCP.0000000000000866"
"33055230","Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis","Goossens SN, Sampson SL, Van Rie A.","Clin Microbiol Rev. 2020 Oct 14;34(1):e00141-20. doi: 10.1128/CMR.00141-20. Print 2020 Dec 16.","Goossens SN","Clin Microbiol Rev","2020","2020/10/15","PMC7566895","","10.1128/CMR.00141-20"
"29950810","Linezolid: a review of its properties, function, and use in critical care","Hashemian SMR, Farhadi T, Ganjparvar M.","Drug Des Devel Ther. 2018 Jun 18;12:1759-1767. doi: 10.2147/DDDT.S164515. eCollection 2018.","Hashemian SMR","Drug Des Devel Ther","2018","2018/06/29","PMC6014438","","10.2147/DDDT.S164515"
"31526739","Management of drug-resistant tuberculosis","Lange C, Dheda K, Chesov D, Mandalakas AM, Udwadia Z, Horsburgh CR Jr.","Lancet. 2019 Sep 14;394(10202):953-966. doi: 10.1016/S0140-6736(19)31882-3.","Lange C","Lancet","2019","2019/09/19","","","10.1016/S0140-6736(19)31882-3"
"29641838","Drug-resistant tuberculosis: An update on disease burden, diagnosis and treatment","Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda K.","Respirology. 2018 Jul;23(7):656-673. doi: 10.1111/resp.13304. Epub 2018 Apr 11.","Lange C","Respirology","2018","2018/04/12","","","10.1111/resp.13304"
"35342000","Drug resistant TB - latest developments in epidemiology, diagnostics and management","Tiberi S, Utjesanovic N, Galvin J, Centis R, D'Ambrosio L, van den Boom M, Zumla A, Migliori GB.","Int J Infect Dis. 2022 Nov;124 Suppl 1:S20-S25. doi: 10.1016/j.ijid.2022.03.026. Epub 2022 Mar 25.","Tiberi S","Int J Infect Dis","2022","2022/03/28","","","10.1016/j.ijid.2022.03.026"
"33400226","Neurotuberculosis: an update","Cherian A, Ajitha KC, Iype T, Divya KP.","Acta Neurol Belg. 2021 Feb;121(1):11-21. doi: 10.1007/s13760-020-01575-0. Epub 2021 Jan 5.","Cherian A","Acta Neurol Belg","2021","2021/01/05","","","10.1007/s13760-020-01575-0"
"30548290","Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging","Li Y, Sun F, Zhang W.","Drug Dev Res. 2019 Feb;80(1):98-105. doi: 10.1002/ddr.21498. Epub 2018 Dec 11.","Li Y","Drug Dev Res","2019","2018/12/15","PMC6590425","","10.1002/ddr.21498"
"35373160","The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: A genotypic analysis","Walker TM, Miotto P, Köser CU, Fowler PW, Knaggs J, Iqbal Z, Hunt M, Chindelevitch L, Farhat M, Cirillo DM, Comas I, Posey J, Omar SV, Peto TE, Suresh A, Uplekar S, Laurent S, Colman RE, Nathanson CM, Zignol M, Walker AS; CRyPTIC Consortium; Seq&Treat Consortium; Crook DW, Ismail N, Rodwell TC.","Lancet Microbe. 2022 Apr;3(4):e265-e273. doi: 10.1016/S2666-5247(21)00301-3.","Walker TM","Lancet Microbe","2022","2022/04/04","PMC7612554","EMS140756","10.1016/S2666-5247(21)00301-3"
"35459278","CinA mediates multidrug tolerance in Mycobacterium tuberculosis","Kreutzfeldt KM, Jansen RS, Hartman TE, Gouzy A, Wang R, Krieger IV, Zimmerman MD, Gengenbacher M, Sarathy JP, Xie M, Dartois V, Sacchettini JC, Rhee KY, Schnappinger D, Ehrt S.","Nat Commun. 2022 Apr 22;13(1):2203. doi: 10.1038/s41467-022-29832-1.","Kreutzfeldt KM","Nat Commun","2022","2022/04/23","PMC9033802","","10.1038/s41467-022-29832-1"
"36868253","Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement","Domínguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gröschel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR Jr, Lange C; TBnet and RESIST-TB networks.","Lancet Infect Dis. 2023 Apr;23(4):e122-e137. doi: 10.1016/S1473-3099(22)00875-1. Epub 2023 Feb 28.","Domínguez J","Lancet Infect Dis","2023","2023/03/03","","","10.1016/S1473-3099(22)00875-1"
"33299175","Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline","Guo H, Courbon GM, Bueler SA, Mai J, Liu J, Rubinstein JL.","Nature. 2021 Jan;589(7840):143-147. doi: 10.1038/s41586-020-3004-3. Epub 2020 Dec 9.","Guo H","Nature","2021","2020/12/10","","","10.1038/s41586-020-3004-3"
"35175905","An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)","Esmail A, Oelofse S, Lombard C, Perumal R, Mbuthini L, Goolam Mahomed A, Variava E, Black J, Oluboyo P, Gwentshu N, Ngam E, Ackerman T, Marais L, Mottay L, Meier S, Pooran A, Tomasicchio M, Te Riele J, Derendinger B, Ndjeka N, Maartens G, Warren R, Martinson N, Dheda K.","Am J Respir Crit Care Med. 2022 May 15;205(10):1214-1227. doi: 10.1164/rccm.202107-1779OC.","Esmail A","Am J Respir Crit Care Med","2022","2022/02/17","","","10.1164/rccm.202107-1779OC"
"36275027","Evolution of Mycobacterium tuberculosis drug resistance in the genomic era","Nimmo C, Millard J, Faulkner V, Monteserin J, Pugh H, Johnson EO.","Front Cell Infect Microbiol. 2022 Oct 7;12:954074. doi: 10.3389/fcimb.2022.954074. eCollection 2022.","Nimmo C","Front Cell Infect Microbiol","2022","2022/10/24","PMC9585206","","10.3389/fcimb.2022.954074"
"34153525","Clofazimine susceptibility testing of Mycobacterium avium complex and Mycobacterium abscessus: a meta-analysis study","Hajikhani B, Nasiri MJ, Hosseini SS, Khalili F, Karimi-Yazdi M, Hematian A, Nojookambari NY, Goudarzi M, Dadashi M, Mirsaeidi M.","J Glob Antimicrob Resist. 2021 Sep;26:188-193. doi: 10.1016/j.jgar.2021.06.002. Epub 2021 Jun 19.","Hajikhani B","J Glob Antimicrob Resist","2021","2021/06/21","","","10.1016/j.jgar.2021.06.002"
"33927718","Repurposing Immunomodulatory Drugs to Combat Tuberculosis","Fatima S, Bhaskar A, Dwivedi VP.","Front Immunol. 2021 Apr 13;12:645485. doi: 10.3389/fimmu.2021.645485. eCollection 2021.","Fatima S","Front Immunol","2021","2021/04/30","PMC8076598","","10.3389/fimmu.2021.645485"
"32361756","Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid","Kadura S, King N, Nakhoul M, Zhu H, Theron G, Köser CU, Farhat M.","J Antimicrob Chemother. 2020 Aug 1;75(8):2031-2043. doi: 10.1093/jac/dkaa136.","Kadura S","J Antimicrob Chemother","2020","2020/05/04","PMC7825472","","10.1093/jac/dkaa136"
"36255328","Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs","Wu SH, Xiao YX, Hsiao HC, Jou R.","Microbiol Spectr. 2022 Dec 21;10(6):e0260522. doi: 10.1128/spectrum.02605-22. Epub 2022 Oct 18.","Wu SH","Microbiol Spectr","2022","2022/10/18","PMC9769975","","10.1128/spectrum.02605-22"
"32369020","The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection","Giraud-Gatineau A, Coya JM, Maure A, Biton A, Thomson M, Bernard EM, Marrec J, Gutierrez MG, Larrouy-Maumus G, Brosch R, Gicquel B, Tailleux L.","Elife. 2020 May 4;9:e55692. doi: 10.7554/eLife.55692.","Giraud-Gatineau A","Elife","2020","2020/05/06","PMC7200153","","10.7554/eLife.55692"
"35944070","Genome-wide association studies of global Mycobacterium tuberculosis resistance to 13 antimicrobials in 10,228 genomes identify new resistance mechanisms","The CRyPTIC Consortium.","PLoS Biol. 2022 Aug 9;20(8):e3001755. doi: 10.1371/journal.pbio.3001755. eCollection 2022 Aug.","The CRyPTIC Consortium","PLoS Biol","2022","2022/08/09","PMC9363015","","10.1371/journal.pbio.3001755"
"35745490","Effectiveness of the Novel Anti-TB Bedaquiline against Drug-Resistant TB in Africa: A Systematic Review of the Literature","Traoré AN, Rikhotso MC, Banda NT, Mashilo MS, Ngandu JPK, Mavumengwana V, Loxton AG, Kinnear C, Potgieter N, Heysell S, Warren R.","Pathogens. 2022 Jun 1;11(6):636. doi: 10.3390/pathogens11060636.","Traoré AN","Pathogens","2022","2022/06/24","PMC9229213","","10.3390/pathogens11060636"
"30261266","Genetics and roadblocks of drug resistant tuberculosis","Perdigão J, Portugal I.","Infect Genet Evol. 2019 Aug;72:113-130. doi: 10.1016/j.meegid.2018.09.023. Epub 2018 Sep 24.","Perdigão J","Infect Genet Evol","2019","2018/09/28","","","10.1016/j.meegid.2018.09.023"
"30706339","Alanine dehydrogenases in mycobacteria","Jeong JA, Oh JI.","J Microbiol. 2019 Feb;57(2):81-92. doi: 10.1007/s12275-019-8543-7. Epub 2019 Jan 31.","Jeong JA","J Microbiol","2019","2019/02/02","","","10.1007/s12275-019-8543-7"
"32372202","Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus","Adeniji AA, Knoll KE, Loots DT.","Appl Microbiol Biotechnol. 2020 Jul;104(13):5633-5662. doi: 10.1007/s00253-020-10606-y. Epub 2020 May 5.","Adeniji AA","Appl Microbiol Biotechnol","2020","2020/05/07","","","10.1007/s00253-020-10606-y"
"36817137","Clofazimine for the treatment of tuberculosis","Stadler JAM, Maartens G, Meintjes G, Wasserman S.","Front Pharmacol. 2023 Feb 2;14:1100488. doi: 10.3389/fphar.2023.1100488. eCollection 2023.","Stadler JAM","Front Pharmacol","2023","2023/02/23","PMC9932205","","10.3389/fphar.2023.1100488"
"32521000","Delamanid Resistance: Update and Clinical Management","Nguyen TVA, Anthony RM, Cao TTH, Bañuls AL, Nguyen VAT, Vu DH, Nguyen NV, Alffenaar JC.","Clin Infect Dis. 2020 Dec 15;71(12):3252-3259. doi: 10.1093/cid/ciaa755.","Nguyen TVA","Clin Infect Dis","2020","2020/06/11","","","10.1093/cid/ciaa755"
"30029909","Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)","Liu Y, Matsumoto M, Ishida H, Ohguro K, Yoshitake M, Gupta R, Geiter L, Hafkin J.","Tuberculosis (Edinb). 2018 Jul;111:20-30. doi: 10.1016/j.tube.2018.04.008. Epub 2018 May 3.","Liu Y","Tuberculosis (Edinb)","2018","2018/07/22","","","10.1016/j.tube.2018.04.008"
"34593898","Genetic diversity of candidate loci linked to Mycobacterium tuberculosis resistance to bedaquiline, delamanid and pretomanid","Gómez-González PJ, Perdigao J, Gomes P, Puyen ZM, Santos-Lazaro D, Napier G, Hibberd ML, Viveiros M, Portugal I, Campino S, Phelan JE, Clark TG.","Sci Rep. 2021 Sep 30;11(1):19431. doi: 10.1038/s41598-021-98862-4.","Gómez-González PJ","Sci Rep","2021","2021/10/01","PMC8484543","","10.1038/s41598-021-98862-4"
"36409105","The ddn Trp20Stop Mutation and Its Association with Lineage 4.5 and Resistance to Delamanid and Pretomanid in Mycobacterium tuberculosis","Mansjö M, Karlsson Lindsjö O, Grönfors Seeth C, Groenheit R, Werngren J.","Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0102622. doi: 10.1128/aac.01026-22. Epub 2022 Nov 21.","Mansjö M","Antimicrob Agents Chemother","2022","2022/11/21","PMC9765023","","10.1128/aac.01026-22"
"29412643","The Expanding Diversity of Mycobacterium tuberculosis Drug Targets","Wellington S, Hung DT.","ACS Infect Dis. 2018 May 11;4(5):696-714. doi: 10.1021/acsinfecdis.7b00255. Epub 2018 Feb 15.","Wellington S","ACS Infect Dis","2018","2018/02/08","","","10.1021/acsinfecdis.7b00255"
"35465240","Whole genome sequencing-based drug resistance predictions of multidrug-resistant Mycobacterium tuberculosis isolates from Tanzania","Mbelele PM, Utpatel C, Sauli E, Mpolya EA, Mutayoba BK, Barilar I, Dreyer V, Merker M, Sariko ML, Swema BM, Mmbaga BT, Gratz J, Addo KK, Pletschette M, Niemann S, Houpt ER, Mpagama SG, Heysell SK.","JAC Antimicrob Resist. 2022 Apr 21;4(2):dlac042. doi: 10.1093/jacamr/dlac042. eCollection 2022 Apr.","Mbelele PM","JAC Antimicrob Resist","2022","2022/04/25","PMC9021016","","10.1093/jacamr/dlac042"
"36209317","Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update","Rajendran A, Palaniyandi K.","Curr Microbiol. 2022 Oct 8;79(11):348. doi: 10.1007/s00284-022-03032-y.","Rajendran A","Curr Microbiol","2022","2022/10/08","","","10.1007/s00284-022-03032-y"
"29187395","New Approaches and Therapeutic Options for Mycobacterium tuberculosis in a Dormant State","Caño-Muñiz S, Anthony R, Niemann S, Alffenaar JC.","Clin Microbiol Rev. 2017 Nov 29;31(1):e00060-17. doi: 10.1128/CMR.00060-17. Print 2018 Jan.","Caño-Muñiz S","Clin Microbiol Rev","2017","2017/12/01","PMC5740979","","10.1128/CMR.00060-17"
"34214699","Prevalence of Mycobacterium tuberculosis resistant to bedaquiline and delamanid in China","He W, Liu C, Liu D, Ma A, Song Y, He P, Bao J, Li Y, Zhao B, Fan J, Cheng Q, Zhao Y.","J Glob Antimicrob Resist. 2021 Sep;26:241-248. doi: 10.1016/j.jgar.2021.06.007. Epub 2021 Jun 30.","He W","J Glob Antimicrob Resist","2021","2021/07/02","","","10.1016/j.jgar.2021.06.007"
"34752308","Pre-conference workshop on drug resistant TB - NATCON 2020","Singla R, Chadha SS, Bhatnagar A, Solanki R, Khanna A.","Indian J Tuberc. 2021 Oct;68(4):428-430. doi: 10.1016/j.ijtb.2021.02.016. Epub 2021 Mar 4.","Singla R","Indian J Tuberc","2021","2021/11/09","","","10.1016/j.ijtb.2021.02.016"
"35407536","Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Mycobacterium tuberculosis Isolates","Park S, Jung J, Kim J, Han SB, Ryoo S.","J Clin Med. 2022 Mar 30;11(7):1927. doi: 10.3390/jcm11071927.","Park S","J Clin Med","2022","2022/04/12","PMC9000149","","10.3390/jcm11071927"
"34680823","Genetic Profile of Linezolid-Resistant M. tuberculosis Clinical Strains from Moscow","Ushtanit A, Mikhailova Y, Lyubimova A, Makarova M, Safonova S, Filippov A, Borisov S, Zimenkov D.","Antibiotics (Basel). 2021 Oct 13;10(10):1243. doi: 10.3390/antibiotics10101243.","Ushtanit A","Antibiotics (Basel)","2021","2021/10/23","PMC8532644","","10.3390/antibiotics10101243"
"34958863","Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid","Kim S, Louie A, Drusano GL, Almoslem M, Kim S, Myrick J, Nole J, Duncanson B, Peloquin CA, Scanga CA, Yamada W, Neely M, Schmidt S.","Int J Antimicrob Agents. 2022 Feb;59(2):106509. doi: 10.1016/j.ijantimicag.2021.106509. Epub 2021 Dec 25.","Kim S","Int J Antimicrob Agents","2022","2021/12/27","","","10.1016/j.ijantimicag.2021.106509"
"36448833","Spontaneous Mutational Patterns and Novel Mutations for Delamanid Resistance in Mycobacterium tuberculosis","Liu Y, Shi J, Li L, Wu T, Chu P, Pang Y, Guo Y, Gao M, Lu J.","Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0053122. doi: 10.1128/aac.00531-22. Epub 2022 Nov 30.","Liu Y","Antimicrob Agents Chemother","2022","2022/11/30","PMC9765178","","10.1128/aac.00531-22"
"36195000","Bedaquiline resistant Mycobacterium tuberculosis clinical isolates with and without rv0678 mutations have similar growth patterns under varying BDQ drug pressure","Saeed DK, Ashraf J, Hasan Z, Shakoor S, Kanji A, Hasan R.","Tuberculosis (Edinb). 2022 Dec;137:102266. doi: 10.1016/j.tube.2022.102266. Epub 2022 Sep 28.","Saeed DK","Tuberculosis (Edinb)","2022","2022/10/04","","","10.1016/j.tube.2022.102266"
"29523322","Mechanisms of resistance to delamanid, a drug for Mycobacterium tuberculosis","Fujiwara M, Kawasaki M, Hariguchi N, Liu Y, Matsumoto M.","Tuberculosis (Edinb). 2018 Jan;108:186-194. doi: 10.1016/j.tube.2017.12.006. Epub 2017 Dec 30.","Fujiwara M","Tuberculosis (Edinb)","2018","2018/03/11","","","10.1016/j.tube.2017.12.006"
"32209979","Whole Genome Sequencing for the Analysis of Drug Resistant Strains of Mycobacterium tuberculosis: A Systematic Review for Bedaquiline and Delamanid","Nieto Ramirez LM, Quintero Vargas K, Diaz G.","Antibiotics (Basel). 2020 Mar 23;9(3):133. doi: 10.3390/antibiotics9030133.","Nieto Ramirez LM","Antibiotics (Basel)","2020","2020/03/27","PMC7148535","","10.3390/antibiotics9030133"
"35260883","Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid","Bateson A, Ortiz Canseco J, McHugh TD, Witney AA, Feuerriegel S, Merker M, Kohl TA, Utpatel C, Niemann S, Andres S, Kranzer K, Maurer FP, Ghodousi A, Borroni E, Cirillo DM, Wijkander M, Toro JC, Groenheit R, Werngren J, Machado D, Viveiros M, Warren RM, Sirgel F, Dippenaar A, Köser CU, Sun E, Timm J.","J Antimicrob Chemother. 2022 May 29;77(6):1685-1693. doi: 10.1093/jac/dkac070.","Bateson A","J Antimicrob Chemother","2022","2022/03/09","PMC9155602","","10.1093/jac/dkac070"
"37003285","Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis","Sonnenkalb L, Carter JJ, Spitaleri A, Iqbal Z, Hunt M, Malone KM, Utpatel C, Cirillo DM, Rodrigues C, Nilgiriwala KS, Fowler PW, Merker M, Niemann S; Comprehensive Resistance Prediction for Tuberculosis: an International Consortium.","Lancet Microbe. 2023 May;4(5):e358-e368. doi: 10.1016/S2666-5247(23)00002-2. Epub 2023 Mar 29.","Sonnenkalb L","Lancet Microbe","2023","2023/04/01","PMC10156607","","10.1016/S2666-5247(23)00002-2"
"36045474","Whole genome sequencing of Bulgarian rifampicin resistant Mycobacterium tuberculosis strains","Yordanova S, Bachiyska E, Tagliani E, Baykova A, Atanasova Y, Spitaleri A, Cirillo DM.","Folia Med (Plovdiv). 2022 Aug 31;64(4):633-640. doi: 10.3897/folmed.64.e70554.","Yordanova S","Folia Med (Plovdiv)","2022","2022/08/31","","","10.3897/folmed.64.e70554"
"36106884","Population Pharmacokinetic Modeling of Bedaquiline among Multidrug-Resistant Pulmonary Tuberculosis Patients from China","Zou J, Chen S, Rao W, Fu L, Zhang J, Liao Y, Zhang Y, Lv N, Deng G, Yang S, Lin L, Li L, Liu S, Qu J.","Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0081122. doi: 10.1128/aac.00811-22. Epub 2022 Sep 15.","Zou J","Antimicrob Agents Chemother","2022","2022/09/15","PMC9578397","","10.1128/aac.00811-22"
"37193296","Mycobacterium tuberculosis Intra-Host Evolution Among Drug-Resistant Tuberculosis Patients Failing Treatment","Perumal R, Khan A, Naidoo K, Ngema SL, Nandlal L, Padayatchi N, Dookie N.","Infect Drug Resist. 2023 May 9;16:2849-2859. doi: 10.2147/IDR.S408976. eCollection 2023.","Perumal R","Infect Drug Resist","2023","2023/05/16","PMC10182815","","10.2147/IDR.S408976"
"32868333","Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-Naive Patients","Reichmuth ML, Hömke R, Zürcher K, Sander P, Avihingsanon A, Collantes J, Loiseau C, Borrell S, Reinhard M, Wilkinson RJ, Yotebieng M, Fenner L, Böttger EC, Gagneux S, Egger M, Keller PM.","Antimicrob Agents Chemother. 2020 Oct 20;64(11):e00513-20. doi: 10.1128/AAC.00513-20. Print 2020 Oct 20.","Reichmuth ML","Antimicrob Agents Chemother","2020","2020/09/02","PMC7577131","","10.1128/AAC.00513-20"
"31981638","Reduced susceptibility and resistance to bedaquiline in clinical M. tuberculosis isolates","Peretokina IV, Krylova LY, Antonova OV, Kholina MS, Kulagina EV, Nosova EY, Safonova SG, Borisov SE, Zimenkov DV.","J Infect. 2020 May;80(5):527-535. doi: 10.1016/j.jinf.2020.01.007. Epub 2020 Jan 23.","Peretokina IV","J Infect","2020","2020/01/26","","","10.1016/j.jinf.2020.01.007"
"35134182","Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study","Wasserman S, Brust JCM, Abdelwahab MT, Little F, Denti P, Wiesner L, Gandhi NR, Meintjes G, Maartens G.","J Antimicrob Chemother. 2022 Mar 31;77(4):1146-1154. doi: 10.1093/jac/dkac019.","Wasserman S","J Antimicrob Chemother","2022","2022/02/08","PMC7612559","EMS140905","10.1093/jac/dkac019"
"35524232","Evolution and spread of a highly drug resistant strain of Mycobacterium tuberculosis in Papua New Guinea","Bainomugisa A, Lavu E, Pandey S, Majumdar S, Banamu J, Coulter C, Marais B, Coin L, Graham SM, du Cros P.","BMC Infect Dis. 2022 May 6;22(1):437. doi: 10.1186/s12879-022-07414-2.","Bainomugisa A","BMC Infect Dis","2022","2022/05/06","PMC9077924","","10.1186/s12879-022-07414-2"
"32060065","Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients","Nimmo C, Millard J, Brien K, Moodley S, van Dorp L, Lutchminarain K, Wolf A, Grant AD, Balloux F, Pym AS, Padayatchi N, O'Donnell M.","Eur Respir J. 2020 Jun 4;55(6):1902383. doi: 10.1183/13993003.02383-2019. Print 2020 Jun.","Nimmo C","Eur Respir J","2020","2020/02/16","PMC7270361","","10.1183/13993003.02383-2019"
"35760475","Recent updates in diagnosis and management of drug-resistant tuberculosis in India: A paradigm shift and the way ahead during the COVID-19 crisis","Gupta M, Ish P, Malhotra N.","Indian J Tuberc. 2022 Jul;69(3):264-267. doi: 10.1016/j.ijtb.2021.08.013. Epub 2021 Aug 16.","Gupta M","Indian J Tuberc","2022","2022/06/27","PMC8366038","","10.1016/j.ijtb.2021.08.013"
"34174037","Linezolid resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Iran","Khosravi AD, Tabandeh MR, Shahi F, Salmanzadeh S.","Acta Microbiol Immunol Hung. 2021 Jun 24. doi: 10.1556/030.2021.01490. Online ahead of print.","Khosravi AD","Acta Microbiol Immunol Hung","2021","2021/06/26","","","10.1556/030.2021.01490"
"35613072","Emergence of multi-drug-resistant Mycobacterium tuberculosis in Niger: A snapshot based on whole-genome sequencing","Harouna Hamidou Z, Morsli M, Mamadou S, Drancourt M, Saad J.","PLoS Negl Trop Dis. 2022 May 25;16(5):e0010443. doi: 10.1371/journal.pntd.0010443. eCollection 2022 May.","Harouna Hamidou Z","PLoS Negl Trop Dis","2022","2022/05/25","PMC9132302","","10.1371/journal.pntd.0010443"
"34745058","Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan","Wu SH, Chan HH, Hsiao HC, Jou R.","Front Microbiol. 2021 Oct 22;12:754249. doi: 10.3389/fmicb.2021.754249. eCollection 2021.","Wu SH","Front Microbiol","2021","2021/11/08","PMC8569445","","10.3389/fmicb.2021.754249"
"29866864","Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model","Drusano GL, Myrick J, Maynard M, Nole J, Duncanson B, Brown D, Schmidt S, Neely M, Scanga CA, Peloquin C, Louie A.","Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00221-18. doi: 10.1128/AAC.00221-18. Print 2018 Aug.","Drusano GL","Antimicrob Agents Chemother","2018","2018/06/06","PMC6105790","","10.1128/AAC.00221-18"
"31081017","Linezolid resistance in patients with drug-resistant TB and treatment failure in South Africa","Wasserman S, Louw G, Ramangoaela L, Barber G, Hayes C, Omar SV, Maartens G, Barry C, Song T, Meintjes G.","J Antimicrob Chemother. 2019 Aug 1;74(8):2377-2384. doi: 10.1093/jac/dkz206.","Wasserman S","J Antimicrob Chemother","2019","2019/05/14","PMC6640298","","10.1093/jac/dkz206"
"35447056","atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure","Le Ray LF, Aubry A, Sougakoff W, Revest M, Robert J, Bonnet I, Veziris N, Morel F.","Emerg Infect Dis. 2022 May;28(5):1062-1064. doi: 10.3201/eid2805.212517.","Le Ray LF","Emerg Infect Dis","2022","2022/04/21","PMC9045433","","10.3201/eid2805.212517"
"30236529","Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens","Cho EH, Huh HJ, Song DJ, Lee SH, Kim CK, Shin SY, Ki CS, Jhun BW, Moon SM, Kwon OJ, Koh WJ, Lee NY.","Diagn Microbiol Infect Dis. 2019 Feb;93(2):107-111. doi: 10.1016/j.diagmicrobio.2018.08.008. Epub 2018 Aug 29.","Cho EH","Diagn Microbiol Infect Dis","2019","2018/09/22","","","10.1016/j.diagmicrobio.2018.08.008"
"29437627","Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii","Bakuła Z, Modrzejewska M, Pennings L, Proboszcz M, Safianowska A, Bielecki J, van Ingen J, Jagielski T.","Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01788-17. doi: 10.1128/AAC.01788-17. Print 2018 Apr.","Bakuła Z","Antimicrob Agents Chemother","2018","2018/02/14","PMC5913922","","10.1128/AAC.01788-17"
"32032366","Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering","Lee BM, Harold LK, Almeida DV, Afriat-Jurnou L, Aung HL, Forde BM, Hards K, Pidot SJ, Ahmed FH, Mohamed AE, Taylor MC, West NP, Stinear TP, Greening C, Beatson SA, Nuermberger EL, Cook GM, Jackson CJ.","PLoS Pathog. 2020 Feb 7;16(2):e1008287. doi: 10.1371/journal.ppat.1008287. eCollection 2020 Feb.","Lee BM","PLoS Pathog","2020","2020/02/08","PMC7032734","","10.1371/journal.ppat.1008287"
"34517802","Current Perspective of ATP Synthase Inhibitors in the Management of the Tuberculosis","Divita KM, Khatik GL.","Curr Top Med Chem. 2021;21(18):1623-1643. doi: 10.2174/1568026621666210913122346.","Divita KM","Curr Top Med Chem","2021","2021/09/14","","","10.2174/1568026621666210913122346"
"29382761","Plasticity of Mycobacterium tuberculosis NADH dehydrogenases and their role in virulence","Vilchèze C, Weinrick B, Leung LW, Jacobs WR Jr.","Proc Natl Acad Sci U S A. 2018 Feb 13;115(7):1599-1604. doi: 10.1073/pnas.1721545115. Epub 2018 Jan 30.","Vilchèze C","Proc Natl Acad Sci U S A","2018","2018/02/01","PMC5816213","","10.1073/pnas.1721545115"
"30948178","Mycobacterium tuberculosis cysteine biosynthesis genes mec+-cysO-cysM confer resistance to clofazimine","Burns-Huang K, Mundhra S.","Tuberculosis (Edinb). 2019 Mar;115:63-66. doi: 10.1016/j.tube.2019.02.002. Epub 2019 Feb 6.","Burns-Huang K","Tuberculosis (Edinb)","2019","2019/04/06","","","10.1016/j.tube.2019.02.002"
"35624432","Prediction of drug resistance profile of multidrug-resistant Mycobacterium tuberculosis (MDR-MTB) isolates from newly diagnosed case by whole genome sequencing (WGS): a study from a high tuberculosis burden country","Sun W, Gui X, Wu Z, Zhang Y, Yan L.","BMC Infect Dis. 2022 May 27;22(1):499. doi: 10.1186/s12879-022-07482-4.","Sun W","BMC Infect Dis","2022","2022/05/27","PMC9137048","","10.1186/s12879-022-07482-4"
"29269090","Assessment and modelling of antibacterial combination regimens","Rao GG, Li J, Garonzik SM, Nation RL, Forrest A.","Clin Microbiol Infect. 2018 Jul;24(7):689-696. doi: 10.1016/j.cmi.2017.12.004. Epub 2017 Dec 18.","Rao GG","Clin Microbiol Infect","2018","2017/12/23","","","10.1016/j.cmi.2017.12.004"
"34315374","Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors","Nandi S, Saxena AK.","Curr Top Med Chem. 2021;21(21):1922-1942. doi: 10.2174/1568026621666210727165742.","Nandi S","Curr Top Med Chem","2021","2021/07/28","","","10.2174/1568026621666210727165742"
"36533863","Myoinositol and methyl stearate increases rifampicin susceptibility among drug-resistant Mycobacterium tuberculosis expressing Rv1819c","Nirmal CR, Rajadas SE, Balasubramanian M, Mohanvel SK, Aathi MS, Munishankar S, Chilamakuru NB, Thiruvenkadam K, Pandiya Raj AK, Paraman R, Dusthackeer A.","Chem Biol Drug Des. 2023 Apr;101(4):883-895. doi: 10.1111/cbdd.14197. Epub 2023 Jan 5.","Nirmal CR","Chem Biol Drug Des","2023","2022/12/19","","","10.1111/cbdd.14197"
"29891191","Clofazimine drug susceptibility testing for Mycobacterium tuberculosis: the case of using the right diluent","Sng LH, Peh JWL, Kee MTL, Ya'akob NBM, Ong RT, Wong CW, Chee CBE, Wang YT.","Pathology. 2018 Aug;50(5):549-553. doi: 10.1016/j.pathol.2018.01.006. Epub 2018 Jun 8.","Sng LH","Pathology","2018","2018/06/13","","","10.1016/j.pathol.2018.01.006"
"35694543","Whole Genome Sequencing Identifies Novel Mutations Associated With Bedaquiline Resistance in Mycobacterium tuberculosis","Guo Q, Bi J, Lin Q, Ye T, Wang Z, Wang Z, Liu L, Zhang G.","Front Cell Infect Microbiol. 2022 May 27;12:807095. doi: 10.3389/fcimb.2022.807095. eCollection 2022.","Guo Q","Front Cell Infect Microbiol","2022","2022/06/13","PMC9184757","","10.3389/fcimb.2022.807095"
"33480344","ATP Synthase, an Emerging Target in TB Drug Discovery: Review of SAR and Clinical Pharmacology of Diarylquinoline Inhibitors","Dhulap A, Banerjee P.","Curr Drug Targets. 2021;22(11):1207-1221. doi: 10.2174/1389450122666210122084332.","Dhulap A","Curr Drug Targets","2021","2021/01/22","","","10.2174/1389450122666210122084332"
"36192704","Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates","Singh K, Sharma S, Banerjee T, Gupta A, Anupurba S.","BMC Microbiol. 2022 Oct 3;22(1):236. doi: 10.1186/s12866-022-02622-x.","Singh K","BMC Microbiol","2022","2022/10/03","PMC9531458","","10.1186/s12866-022-02622-x"
"32361247","Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment","Nimmo C, Brien K, Millard J, Grant AD, Padayatchi N, Pym AS, O'Donnell M, Goldstein R, Breuer J, Balloux F.","EBioMedicine. 2020 May;55:102747. doi: 10.1016/j.ebiom.2020.102747. Epub 2020 Apr 28.","Nimmo C","EBioMedicine","2020","2020/05/04","PMC7195533","","10.1016/j.ebiom.2020.102747"
"31225608","Characterization of linezolid-resistance-associated mutations in Mycobacterium tuberculosis through WGS","Pi R, Liu Q, Jiang Q, Gao Q.","J Antimicrob Chemother. 2019 Jul 1;74(7):1795-1798. doi: 10.1093/jac/dkz150.","Pi R","J Antimicrob Chemother","2019","2019/06/22","","","10.1093/jac/dkz150"
"33042066","In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates","Degiacomi G, Sammartino JC, Sinigiani V, Marra P, Urbani A, Pasca MR.","Front Microbiol. 2020 Sep 17;11:559469. doi: 10.3389/fmicb.2020.559469. eCollection 2020.","Degiacomi G","Front Microbiol","2020","2020/10/12","PMC7527418","","10.3389/fmicb.2020.559469"
"33257709","Bedaquiline reprograms central metabolism to reveal glycolytic vulnerability in Mycobacterium tuberculosis","Mackenzie JS, Lamprecht DA, Asmal R, Adamson JH, Borah K, Beste DJV, Lee BS, Pethe K, Rousseau S, Krieger I, Sacchettini JC, Glasgow JN, Steyn AJC.","Nat Commun. 2020 Nov 30;11(1):6092. doi: 10.1038/s41467-020-19959-4.","Mackenzie JS","Nat Commun","2020","2020/12/01","PMC7705017","","10.1038/s41467-020-19959-4"
"33130209","Acquisition of clofazimine resistance following bedaquiline treatment for multidrug-resistant tuberculosis","Liu Y, Gao J, Du J, Shu W, Wang L, Wang Y, Xue Z, Li L, Xu S, Pang Y.","Int J Infect Dis. 2021 Jan;102:392-396. doi: 10.1016/j.ijid.2020.10.081. Epub 2020 Oct 29.","Liu Y","Int J Infect Dis","2021","2020/11/01","","","10.1016/j.ijid.2020.10.081"
"31262765","Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan","Ghodousi A, Rizvi AH, Baloch AQ, Ghafoor A, Khanzada FM, Qadir M, Borroni E, Trovato A, Tahseen S, Cirillo DM.","Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00915-19. doi: 10.1128/AAC.00915-19. Print 2019 Sep.","Ghodousi A","Antimicrob Agents Chemother","2019","2019/07/03","PMC6709449","","10.1128/AAC.00915-19"
"36718771","Mutations and insights into the molecular mechanisms of resistance of Mycobacterium tuberculosis to first-line","Rossini NO, Dias MVB.","Genet Mol Biol. 2023 Jan 23;46(1 Suppl 2):e20220261. doi: 10.1590/1678-4685-GMB-2022-0261. eCollection 2023.","Rossini NO","Genet Mol Biol","2023","2023/01/31","PMC9887390","","10.1590/1678-4685-GMB-2022-0261"
"34446095","Prevalence of extensively drug-resistant tuberculosis in a Chinese multidrug-resistant TB cohort after redefinition","Yao C, Guo H, Li Q, Zhang X, Shang Y, Li T, Wang Y, Xue Z, Wang L, Li L, Pang Y.","Antimicrob Resist Infect Control. 2021 Aug 26;10(1):126. doi: 10.1186/s13756-021-00995-8.","Yao C","Antimicrob Resist Infect Control","2021","2021/08/27","PMC8393791","","10.1186/s13756-021-00995-8"
"32143680","Phylogenetically informative mutations in genes implicated in antibiotic resistance in Mycobacterium tuberculosis complex","Merker M, Kohl TA, Barilar I, Andres S, Fowler PW, Chryssanthou E, Ängeby K, Jureen P, Moradigaravand D, Parkhill J, Peacock SJ, Schön T, Maurer FP, Walker T, Köser C, Niemann S.","Genome Med. 2020 Mar 6;12(1):27. doi: 10.1186/s13073-020-00726-5.","Merker M","Genome Med","2020","2020/03/08","PMC7060619","","10.1186/s13073-020-00726-5"
"34670644","Genomic Profiling of Mycobacterium tuberculosis Strains, Myanmar","Aung HL, Nyunt WW, Fong Y, Biggs PJ, Winkworth RC, Lockhart PJ, Yeo TW, Hill PC, Cook GM, Aung ST.","Emerg Infect Dis. 2021 Nov;27(11):2847-2855. doi: 10.3201/eid2711.210726.","Aung HL","Emerg Infect Dis","2021","2021/10/21","PMC8544997","","10.3201/eid2711.210726"
"32446667","Update of SEPAR guideline «Diagnosis and Treatment of Drug-Resistant Tuberculosis»","Caminero JA, García-García JM, Caylà JA, García-Pérez FJ, Palacios JJ, Ruiz-Manzano J.","Arch Bronconeumol (Engl Ed). 2020 Aug;56(8):514-521. doi: 10.1016/j.arbres.2020.03.021. Epub 2020 May 20.","Caminero JA","Arch Bronconeumol (Engl Ed)","2020","2020/05/25","","","10.1016/j.arbres.2020.03.021"
"34543098","Linezolid Population Pharmacokinetics in South African Adults with Drug-Resistant Tuberculosis","Abdelwahab MT, Wasserman S, Brust JCM, Dheda K, Wiesner L, Gandhi NR, Warren RM, Sirgel FA, Meintjes G, Maartens G, Denti P.","Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0138121. doi: 10.1128/AAC.01381-21. Epub 2021 Sep 20.","Abdelwahab MT","Antimicrob Agents Chemother","2021","2021/09/20","PMC8597769","","10.1128/AAC.01381-21"
"35660663","Identification and drug susceptibility testing of the subspecies of Mycobacterium avium complex clinical isolates in mainland China","Li Y, Liu C, Ma A, He W, Qiu Q, Zhao Y, Li Y.","J Glob Antimicrob Resist. 2022 Dec;31:90-97. doi: 10.1016/j.jgar.2022.05.027. Epub 2022 Jun 2.","Li Y","J Glob Antimicrob Resist","2022","2022/06/06","","","10.1016/j.jgar.2022.05.027"
"34460306","Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex","Vargas R Jr, Freschi L, Spitaleri A, Tahseen S, Barilar I, Niemann S, Miotto P, Cirillo DM, Köser CU, Farhat MR.","Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0116421. doi: 10.1128/AAC.01164-21. Epub 2021 Aug 30.","Vargas R Jr","Antimicrob Agents Chemother","2021","2021/08/30","PMC8522733","","10.1128/AAC.01164-21"
"31486393","The Lancet Respiratory Medicine Commission: 2019 update: epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant and incurable tuberculosis","Dheda K, Gumbo T, Maartens G, Dooley KE, Murray M, Furin J, Nardell EA, Warren RM; Lancet Respiratory Medicine drug-resistant tuberculosis Commission group.","Lancet Respir Med. 2019 Sep;7(9):820-826. doi: 10.1016/S2213-2600(19)30263-2.","Dheda K","Lancet Respir Med","2019","2019/09/06","","","10.1016/S2213-2600(19)30263-2"
"36838390","Epidemiology and Drug Resistance Patterns of Mycobacterium tuberculosis in High-Burden Area in Western Siberia, Russia","Kostyukova I, Pasechnik O, Mokrousov I.","Microorganisms. 2023 Feb 8;11(2):425. doi: 10.3390/microorganisms11020425.","Kostyukova I","Microorganisms","2023","2023/02/25","PMC9963218","","10.3390/microorganisms11020425"
"35650702","Clinical standards for the dosing and management of TB drugs","Alffenaar JWC, Stocker SL, Forsman LD, Garcia-Prats A, Heysell SK, Aarnoutse RE, Akkerman OW, Aleksa A, van Altena R, de Oñata WA, Bhavani PK, Van't Boveneind-Vrubleuskaya N, Carvalho ACC, Centis R, Chakaya JM, Cirillo DM, Cho JG, D Ambrosio L, Dalcolmo MP, Denti P, Dheda K, Fox GJ, Hesseling AC, Kim HY, Köser CU, Marais BJ, Margineanu I, Märtson AG, Torrico MM, Nataprawira HM, Ong CWM, Otto-Knapp R, Peloquin CA, Silva DR, Ruslami R, Santoso P, Savic RM, Singla R, Svensson EM, Skrahina A, van Soolingen D, Srivastava S, Tadolini M, Tiberi S, Thomas TA, Udwadia ZF, Vu DH, Zhang W, Mpagama SG, Schön T, Migliori GB.","Int J Tuberc Lung Dis. 2022 Jun 1;26(6):483-499. doi: 10.5588/ijtld.22.0188.","Alffenaar JWC","Int J Tuberc Lung Dis","2022","2022/06/02","PMC9165737","","10.5588/ijtld.22.0188"
"29089153","In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex","Zhang Z, Lu J, Song Y, Pang Y.","Diagn Microbiol Infect Dis. 2018 Jan;90(1):31-34. doi: 10.1016/j.diagmicrobio.2017.09.013. Epub 2017 Sep 22.","Zhang Z","Diagn Microbiol Infect Dis","2018","2017/11/02","","","10.1016/j.diagmicrobio.2017.09.013"
"31672993","Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development","Beites T, O'Brien K, Tiwari D, Engelhart CA, Walters S, Andrews J, Yang HJ, Sutphen ML, Weiner DM, Dayao EK, Zimmerman M, Prideaux B, Desai PV, Masquelin T, Via LE, Dartois V, Boshoff HI, Barry CE 3rd, Ehrt S, Schnappinger D.","Nat Commun. 2019 Oct 31;10(1):4970. doi: 10.1038/s41467-019-12956-2.","Beites T","Nat Commun","2019","2019/11/02","PMC6823465","","10.1038/s41467-019-12956-2"
"32606825","Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro","Hu M, Fu L, Wang B, Xu J, Guo S, Zhao J, Li Y, Chen X, Lu Y.","Infect Drug Resist. 2020 Jun 12;13:1751-1761. doi: 10.2147/IDR.S257145. eCollection 2020.","Hu M","Infect Drug Resist","2020","2020/07/02","PMC7297343","","10.2147/IDR.S257145"
"30872297","An update on multidrug-resistant tuberculosis ","Park M, Satta G, Kon OM.","Clin Med (Lond). 2019 Mar;19(2):135-139. doi: 10.7861/clinmedicine.19-2-135.","Park M","Clin Med (Lond)","2019","2019/03/16","PMC6454369","","10.7861/clinmedicine.19-2-135"
"34503982","Emergence of bedaquiline resistance in a high tuberculosis burden country","Chesov E, Chesov D, Maurer FP, Andres S, Utpatel C, Barilar I, Donica A, Reimann M, Niemann S, Lange C, Crudu V, Heyckendorf J, Merker M.","Eur Respir J. 2022 Mar 24;59(3):2100621. doi: 10.1183/13993003.00621-2021. Print 2022 Mar.","Chesov E","Eur Respir J","2022","2021/09/10","PMC8943268","","10.1183/13993003.00621-2021"
"31843996","Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach","Liu Y, Tan Y, Islam MM, Cao Y, Lu X, Zeng S, Hameed HMA, Zhou P, Cai X, Wang S, Mugweru JN, Zhang G, Yin H, Liu J, Nuermberger E, Zhang T.","Antimicrob Agents Chemother. 2020 Feb 21;64(3):e01881-19. doi: 10.1128/AAC.01881-19. Print 2020 Feb 21.","Liu Y","Antimicrob Agents Chemother","2020","2019/12/18","PMC7038284","","10.1128/AAC.01881-19"
"34398674","In Vitro and In Vivo Activity of Oxazolidinone Candidate OTB-658 against Mycobacterium tuberculosis","Guo S, Wang B, Fu L, Chen X, Zhang W, Huang H, Lu Y.","Antimicrob Agents Chemother. 2021 Oct 18;65(11):e0097421. doi: 10.1128/AAC.00974-21. Epub 2021 Aug 16.","Guo S","Antimicrob Agents Chemother","2021","2021/08/16","PMC8522764","","10.1128/AAC.00974-21"
"33077652","Mutations in fbiD (Rv2983) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis","Rifat D, Li SY, Ioerger T, Shah K, Lanoix JP, Lee J, Bashiri G, Sacchettini J, Nuermberger E.","Antimicrob Agents Chemother. 2020 Dec 16;65(1):e01948-20. doi: 10.1128/AAC.01948-20. Print 2020 Dec 16.","Rifat D","Antimicrob Agents Chemother","2020","2020/10/20","PMC7927868","","10.1128/AAC.01948-20"
"30953211","Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis","Wen S, Jing W, Zhang T, Zong Z, Xue Y, Shang Y, Wang F, Huang H, Chu N, Pang Y.","Eur J Clin Microbiol Infect Dis. 2019 Jul;38(7):1293-1296. doi: 10.1007/s10096-019-03551-w. Epub 2019 Apr 5.","Wen S","Eur J Clin Microbiol Infect Dis","2019","2019/04/07","","","10.1007/s10096-019-03551-w"
"36165641","Whole-Genome Sequencing for Resistance Prediction and Transmission Analysis of Mycobacterium tuberculosis Complex Strains from Namibia","Claassens M, Dreyer V, Nepolo E, Mokomele Q, van Rooyen G, Ruswa N, Günther G, Niemann S.","Microbiol Spectr. 2022 Oct 26;10(5):e0158622. doi: 10.1128/spectrum.01586-22. Epub 2022 Sep 27.","Claassens M","Microbiol Spectr","2022","2022/09/27","PMC9603870","","10.1128/spectrum.01586-22"
"36190243","Drug Degradation Caused by mce3R Mutations Confers Contezolid (MRX-I) Resistance in Mycobacterium tuberculosis","Pi R, Chen X, Meng J, Liu Q, Chen Y, Bei C, Wang C, Gao Q.","Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0103422. doi: 10.1128/aac.01034-22. Epub 2022 Oct 3.","Pi R","Antimicrob Agents Chemother","2022","2022/10/03","PMC9578412","","10.1128/aac.01034-22"
"36321819","Synergistic Effect of Q203 Combined with PBTZ169 against Mycobacterium tuberculosis","Nguyen TQ, Hanh BTB, Jeon S, Heo BE, Park Y, Choudhary A, Moon C, Jang J.","Antimicrob Agents Chemother. 2022 Dec 20;66(12):e0044822. doi: 10.1128/aac.00448-22. Epub 2022 Nov 2.","Nguyen TQ","Antimicrob Agents Chemother","2022","2022/11/02","PMC9765072","","10.1128/aac.00448-22"
"30642938","Clofazimine Exposure In Vitro Selects Efflux Pump Mutants and Bedaquiline Resistance","Ismail N, Peters RPH, Ismail NA, Omar SV.","Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02141-18. doi: 10.1128/AAC.02141-18. Print 2019 Mar.","Ismail N","Antimicrob Agents Chemother","2019","2019/01/16","PMC6395909","","10.1128/AAC.02141-18"
"36417506","Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in Mycobacterium tuberculosis","Yan MY, Zheng D, Li SS, Ding XY, Wang CL, Guo XP, Zhan L, Jin Q, Yang J, Sun YC.","Sci Adv. 2022 Nov 25;8(47):eadd5907. doi: 10.1126/sciadv.add5907. Epub 2022 Nov 23.","Yan MY","Sci Adv","2022","2022/11/23","PMC9683719","","10.1126/sciadv.add5907"
"36877083","Circularization of rv0678 for Genotypic Bedaquiline Resistance Testing of Mycobacterium tuberculosis","Limberis JD, Nalyvayko A, Ernst JD, Metcalfe JZ.","Microbiol Spectr. 2023 Mar 6;11(2):e0412722. doi: 10.1128/spectrum.04127-22. Online ahead of print.","Limberis JD","Microbiol Spectr","2023","2023/03/06","PMC10100719","","10.1128/spectrum.04127-22"
"32738481","Molecular characteristics and in vitro susceptibility to bedaquiline of Mycobacterium tuberculosis isolates circulating in Shaanxi, China","Yang J, Pang Y, Zhang T, Xian X, Li Y, Wang R, Wang P, Zhang M, Wang J.","Int J Infect Dis. 2020 Oct;99:163-170. doi: 10.1016/j.ijid.2020.07.044. Epub 2020 Jul 29.","Yang J","Int J Infect Dis","2020","2020/08/02","","","10.1016/j.ijid.2020.07.044"
"34465301","Transmission patterns of rifampicin resistant Mycobacterium tuberculosis complex strains in Cameroon: a genomic epidemiological study","Merker M, Egbe NF, Ngangue YR, Vuchas C, Kohl TA, Dreyer V, Kuaban C, Noeske J, Niemann S, Sander MS.","BMC Infect Dis. 2021 Aug 31;21(1):891. doi: 10.1186/s12879-021-06593-8.","Merker M","BMC Infect Dis","2021","2021/09/01","PMC8406724","","10.1186/s12879-021-06593-8"
"35168150","Quinoline heterocyclic containing plant and marine candidates against drug-resistant Mycobacterium tuberculosis: A systematic drug-ability investigation","Swain SS, Pati S, Hussain T.","Eur J Med Chem. 2022 Mar 15;232:114173. doi: 10.1016/j.ejmech.2022.114173. Epub 2022 Feb 4.","Swain SS","Eur J Med Chem","2022","2022/02/15","","","10.1016/j.ejmech.2022.114173"
"32900827","Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility","Jain P, Garing S, Verma D, Saranathan R, Clute-Reinig N, Gadwa J, Peterson C, Hermansky G, Astashkina Fernandez A, Asare E, Weisbrod TR, Spencer E, Mulholland CV, Berney M, Bell D, Nichols KP, Le Ny AM, Ordway D, Jacobs WR Jr, Somoskovi A, Minch KJ.","J Bacteriol. 2020 Oct 22;202(22):e00411-20. doi: 10.1128/JB.00411-20. Print 2020 Oct 22.","Jain P","J Bacteriol","2020","2020/09/09","PMC7585058","","10.1128/JB.00411-20"
"31138571","In Vitro Activities of Bedaquiline and Delamanid against Nontuberculous Mycobacteria Isolated in Beijing, China","Yu X, Gao X, Li C, Luo J, Wen S, Zhang T, Ma Y, Dong L, Wang F, Huang H.","Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00031-19. doi: 10.1128/AAC.00031-19. Print 2019 Aug.","Yu X","Antimicrob Agents Chemother","2019","2019/05/30","PMC6658755","","10.1128/AAC.00031-19"
"29223615","Differences in drug susceptibility pattern between Mycobacterium avium and Mycobacterium intracellulare isolated in respiratory specimens","Cho EH, Huh HJ, Song DJ, Moon SM, Lee SH, Shin SY, Kim CK, Ki CS, Koh WJ, Lee NY.","J Infect Chemother. 2018 Apr;24(4):315-318. doi: 10.1016/j.jiac.2017.10.022. Epub 2017 Dec 7.","Cho EH","J Infect Chemother","2018","2017/12/11","","","10.1016/j.jiac.2017.10.022"
"29126225","Bedaquiline Resistance: Its Emergence, Mechanism, and Prevention","Nguyen TVA, Anthony RM, Bañuls AL, Nguyen TVA, Vu DH, Alffenaar JC.","Clin Infect Dis. 2018 May 2;66(10):1625-1630. doi: 10.1093/cid/cix992.","Nguyen TVA","Clin Infect Dis","2018","2017/11/11","","","10.1093/cid/cix992"
"32589869","Advanced imaging tools for childhood tuberculosis: potential applications and research needs","Jain SK, Andronikou S, Goussard P, Antani S, Gomez-Pastrana D, Delacourt C, Starke JR, Ordonez AA, Jean-Philippe P, Browning RS, Perez-Velez CM.","Lancet Infect Dis. 2020 Nov;20(11):e289-e297. doi: 10.1016/S1473-3099(20)30177-8. Epub 2020 Jun 23.","Jain SK","Lancet Infect Dis","2020","2020/06/27","PMC7606757","NIHMS1607712","10.1016/S1473-3099(20)30177-8"
"32540971","Evidence for Expanding the Role of Streptomycin in the Management of Drug-Resistant Mycobacterium tuberculosis","Cohen KA, Stott KE, Munsamy V, Manson AL, Earl AM, Pym AS.","Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00860-20. doi: 10.1128/AAC.00860-20. Print 2020 Aug 20.","Cohen KA","Antimicrob Agents Chemother","2020","2020/06/17","PMC7449167","","10.1128/AAC.00860-20"
"35550524","Application of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in the detection of drug resistance of Mycobacterium tuberculosis in re-treated patients","Shi J, He G, Ning H, Wu L, Wu Z, Ye X, Qiu C, Jiang X.","Tuberculosis (Edinb). 2022 Jul;135:102209. doi: 10.1016/j.tube.2022.102209. Epub 2022 Apr 30.","Shi J","Tuberculosis (Edinb)","2022","2022/05/13","","","10.1016/j.tube.2022.102209"
"34986292","Bedaquiline-Resistant Tuberculosis Associated with Rv0678 Mutations","Omar SV, Ismail F, Ndjeka N, Kaniga K, Ismail NA.","N Engl J Med. 2022 Jan 6;386(1):93-94. doi: 10.1056/NEJMc2103049.","Omar SV","N Engl J Med","2022","2022/01/05","","","10.1056/NEJMc2103049"
"31711854","Antitubercular Triazines: Optimization and Intrabacterial Metabolism","Wang X, Inoyama D, Russo R, Li SG, Jadhav R, Stratton TP, Mittal N, Bilotta JA, Singleton E, Kim T, Paget SD, Pottorf RS, Ahn YM, Davila-Pagan A, Kandasamy S, Grady C, Hussain S, Soteropoulos P, Zimmerman MD, Ho HP, Park S, Dartois V, Ekins S, Connell N, Kumar P, Freundlich JS.","Cell Chem Biol. 2020 Feb 20;27(2):172-185.e11. doi: 10.1016/j.chembiol.2019.10.010. Epub 2019 Nov 8.","Wang X","Cell Chem Biol","2020","2019/11/13","PMC7035970","NIHMS1543848","10.1016/j.chembiol.2019.10.010"
"29337135","Defining Bedaquiline Susceptibility, Resistance, Cross-Resistance and Associated Genetic Determinants: A Retrospective Cohort Study","Ismail NA, Omar SV, Joseph L, Govender N, Blows L, Ismail F, Koornhof H, Dreyer AW, Kaniga K, Ndjeka N.","EBioMedicine. 2018 Feb;28:136-142. doi: 10.1016/j.ebiom.2018.01.005. Epub 2018 Jan 9.","Ismail NA","EBioMedicine","2018","2018/01/17","PMC5835552","","10.1016/j.ebiom.2018.01.005"
"35091749","Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa","Haas DW, Abdelwahab MT, van Beek SW, Baker P, Maartens G, Bradford Y, Ritchie MD, Wasserman S, Meintjes G, Beeri K, Gandhi NR, Svensson EM, Denti P, Brust JCM.","J Infect Dis. 2022 Aug 12;226(1):147-156. doi: 10.1093/infdis/jiac024.","Haas DW","J Infect Dis","2022","2022/01/29","PMC9373148","","10.1093/infdis/jiac024"
"35170994","Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis","Yao R, Wang B, Fu L, Li L, You K, Li YG, Lu Y.","Microbiol Spectr. 2022 Feb 23;10(1):e0247721. doi: 10.1128/spectrum.02477-21. Epub 2022 Feb 16.","Yao R","Microbiol Spectr","2022","2022/02/16","PMC8849072","","10.1128/spectrum.02477-21"
"33330134","Terminal Respiratory Oxidases: A Targetables Vulnerability of Mycobacterial Bioenergetics?","Bajeli S, Baid N, Kaur M, Pawar GP, Chaudhari VD, Kumar A.","Front Cell Infect Microbiol. 2020 Nov 23;10:589318. doi: 10.3389/fcimb.2020.589318. eCollection 2020.","Bajeli S","Front Cell Infect Microbiol","2020","2020/12/17","PMC7719681","","10.3389/fcimb.2020.589318"
"30833432","Contribution of Pretomanid to Novel Regimens Containing Bedaquiline with either Linezolid or Moxifloxacin and Pyrazinamide in Murine Models of Tuberculosis","Xu J, Li SY, Almeida DV, Tasneen R, Barnes-Boyle K, Converse PJ, Upton AM, Mdluli K, Fotouhi N, Nuermberger EL.","Antimicrob Agents Chemother. 2019 Apr 25;63(5):e00021-19. doi: 10.1128/AAC.00021-19. Print 2019 May.","Xu J","Antimicrob Agents Chemother","2019","2019/03/06","PMC6496099","","10.1128/AAC.00021-19"
"34782533","Linezolid resistance in Mycobacterium tuberculosis isolates at a tertiary care centre in Mumbai, India","Nambiar R, Tornheim JA, Diricks M, De Bruyne K, Sadani M, Shetty A, Rodrigues C.","Indian J Med Res. 2021 Jul;154(1):85-89. doi: 10.4103/ijmr.IJMR_1168_19.","Nambiar R","Indian J Med Res","2021","2021/11/16","PMC8715694","","10.4103/ijmr.IJMR_1168_19"
"31719182","Transcriptomic Signatures Predict Regulators of Drug Synergy and Clinical Regimen Efficacy against Tuberculosis","Ma S, Jaipalli S, Larkins-Ford J, Lohmiller J, Aldridge BB, Sherman DR, Chandrasekaran S.","mBio. 2019 Nov 12;10(6):e02627-19. doi: 10.1128/mBio.02627-19.","Ma S","mBio","2019","2019/11/14","PMC6851285","","10.1128/mBio.02627-19"
"33832459","Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China","Zheng H, He W, Jiao W, Xia H, Sun L, Wang S, Xiao J, Ou X, Zhao Y, Shen A.","BMC Infect Dis. 2021 Apr 8;21(1):330. doi: 10.1186/s12879-021-06024-8.","Zheng H","BMC Infect Dis","2021","2021/04/09","PMC8028109","","10.1186/s12879-021-06024-8"
"34012425","Low Rate of Acquired Linezolid Resistance in Multidrug-Resistant Tuberculosis Treated With Bedaquiline-Linezolid Combination","Du J, Gao J, Yu Y, Li Q, Bai G, Shu W, Gao M, Liu Y, Wang L, Wang Y, Xue Z, Huo F, Li L, Pang Y.","Front Microbiol. 2021 May 3;12:655653. doi: 10.3389/fmicb.2021.655653. eCollection 2021.","Du J","Front Microbiol","2021","2021/05/20","PMC8126624","","10.3389/fmicb.2021.655653"
"35019778","Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China","Guo Y, Cao Y, Liu H, Yang J, Wang W, Wang B, Li M, Yu F.","Microbiol Spectr. 2022 Feb 23;10(1):e0147521. doi: 10.1128/spectrum.01475-21. Epub 2022 Jan 12.","Guo Y","Microbiol Spectr","2022","2022/01/12","PMC8754148","","10.1128/spectrum.01475-21"
"32667984","Reduced Susceptibility of Mycobacterium tuberculosis to Bedaquiline During Antituberculosis Treatment and Its Correlation With Clinical Outcomes in China","Liu Y, Gao M, Du J, Wang L, Gao J, Shu W, Wang Y, Xue Z, Li L, Pang Y.","Clin Infect Dis. 2021 Nov 2;73(9):e3391-e3397. doi: 10.1093/cid/ciaa1002.","Liu Y","Clin Infect Dis","2021","2020/07/16","","","10.1093/cid/ciaa1002"
"30248414","Whole-genome sequencing reveals genetic signature of bedaquiline resistance in a clinical isolate of Mycobacterium tuberculosis","Chawla K, Martinez E, Kumar A, Shenoy VP, Sintchenko V.","J Glob Antimicrob Resist. 2018 Dec;15:103-104. doi: 10.1016/j.jgar.2018.09.006. Epub 2018 Sep 21.","Chawla K","J Glob Antimicrob Resist","2018","2018/09/25","","","10.1016/j.jgar.2018.09.006"
"35960778","Drug susceptibility profiling and genetic determinants of drug resistance in Mycobacterium simiae isolates obtained from regional tuberculosis reference laboratories of Iran","Daneshfar S, Khosravi AD, Hashemzadeh M.","PLoS One. 2022 Aug 12;17(8):e0267320. doi: 10.1371/journal.pone.0267320. eCollection 2022.","Daneshfar S","PLoS One","2022","2022/08/12","PMC9374208","","10.1371/journal.pone.0267320"
"34795042","In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient","Ghodousi A, Hussain Rizvi A, Khanzada FM, Akhtar N, Ghafoor A, Trovato A, Cirillo DM, Tahseen S.","Eur Respir J. 2022 Mar 24;59(3):2102102. doi: 10.1183/13993003.02102-2021. Print 2022 Mar.","Ghodousi A","Eur Respir J","2022","2021/11/19","PMC8943273","","10.1183/13993003.02102-2021"
"30617089","Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection","Wasserman S, Denti P, Brust JCM, Abdelwahab M, Hlungulu S, Wiesner L, Norman J, Sirgel FA, Warren RM, Esmail A, Dheda K, Gandhi NR, Meintjes G, Maartens G.","Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02164-18. doi: 10.1128/AAC.02164-18. Print 2019 Mar.","Wasserman S","Antimicrob Agents Chemother","2019","2019/01/09","PMC6395899","","10.1128/AAC.02164-18"
"32907992","Characterization of Genomic Variants Associated with Resistance to Bedaquiline and Delamanid in Naive Mycobacterium tuberculosis Clinical Strains","Battaglia S, Spitaleri A, Cabibbe AM, Meehan CJ, Utpatel C, Ismail N, Tahseen S, Skrahina A, Alikhanova N, Mostofa Kamal SM, Barbova A, Niemann S, Groenheit R, Dean AS, Zignol M, Rigouts L, Cirillo DM.","J Clin Microbiol. 2020 Oct 21;58(11):e01304-20. doi: 10.1128/JCM.01304-20. Print 2020 Oct 21.","Battaglia S","J Clin Microbiol","2020","2020/09/10","PMC7587096","","10.1128/JCM.01304-20"
"34889724","Whole genome sequencing reveals large deletions and other loss of function mutations in Mycobacterium tuberculosis drug resistance genes","Gomes LC, Campino S, Marinho CRF, Clark TG, Phelan JE.","Microb Genom. 2021 Dec;7(12):000724. doi: 10.1099/mgen.0.000724.","Gomes LC","Microb Genom","2021","2021/12/10","PMC8767347","","10.1099/mgen.0.000724"
"37338471","Mycobacterium tuberculosis - atpE gene profile of bedaquiline-treated pulmonary tuberculosis patients at the referral hospital Dr. Soetomo, Indonesia","Setyawan MF, Mertaniasih NM, Soedarsono S, Nuha Z, Maladan Y, Matsumoto S.","Int J Mycobacteriol. 2023 Apr-Jun;12(2):122-128. doi: 10.4103/ijmy.ijmy_40_23.","Setyawan MF","Int J Mycobacteriol","2023","2023/06/20","","","10.4103/ijmy.ijmy_40_23"
"29700106","Long-term bedaquiline-related treatment outcomes in patients with extensively drug-resistant tuberculosis from South Africa","Olayanju O, Limberis J, Esmail A, Oelofse S, Gina P, Pietersen E, Fadul M, Warren R, Dheda K.","Eur Respir J. 2018 May 30;51(5):1800544. doi: 10.1183/13993003.00544-2018. Print 2018 May.","Olayanju O","Eur Respir J","2018","2018/04/28","","","10.1183/13993003.00544-2018"
"35550202","First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda","Kabahita JM, Kabugo J, Kakooza F, Adam I, Guido O, Byabajungu H, Namutebi J, Namaganda MM, Lutaaya P, Otim J, Kakembo FE, Kanyerezi S, Nabisubi P, Sserwadda I, Kasule GW, Nakato H, Musisi K, Oola D, Joloba ML, Mboowa G.","Antimicrob Resist Infect Control. 2022 May 12;11(1):68. doi: 10.1186/s13756-022-01101-2.","Kabahita JM","Antimicrob Resist Infect Control","2022","2022/05/13","PMC9102340","","10.1186/s13756-022-01101-2"
"30323043","Mutations in the MAB_2299c TetR Regulator Confer Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus","Richard M, Gutiérrez AV, Viljoen A, Rodriguez-Rincon D, Roquet-Baneres F, Blaise M, Everall I, Parkhill J, Floto RA, Kremer L.","Antimicrob Agents Chemother. 2018 Dec 21;63(1):e01316-18. doi: 10.1128/AAC.01316-18. Print 2019 Jan.","Richard M","Antimicrob Agents Chemother","2018","2018/10/17","PMC6325171","","10.1128/AAC.01316-18"
"31358589","TBAJ-876 Retains Bedaquiline's Activity against Subunits c and ε of Mycobacterium tuberculosis F-ATP Synthase","Sarathy JP, Ragunathan P, Shin J, Cooper CB, Upton AM, Grüber G, Dick T.","Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01191-19. doi: 10.1128/AAC.01191-19. Print 2019 Oct.","Sarathy JP","Antimicrob Agents Chemother","2019","2019/07/31","PMC6761534","","10.1128/AAC.01191-19"
"32398197","Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine","Butov D, Lange C, Heyckendorf J, Kalmykova I, Butova T, Borovok N, Novokhatskaya M, Chesov D.","Int J Tuberc Lung Dis. 2020 May 1;24(5):485-491. doi: 10.5588/ijtld.19.0508.","Butov D","Int J Tuberc Lung Dis","2020","2020/05/14","","","10.5588/ijtld.19.0508"
"29038265","Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis","Xu J, Tasneen R, Peloquin CA, Almeida DV, Li SY, Barnes-Boyle K, Lu Y, Nuermberger E.","Antimicrob Agents Chemother. 2017 Dec 21;62(1):e01692-17. doi: 10.1128/AAC.01692-17. Print 2018 Jan.","Xu J","Antimicrob Agents Chemother","2017","2017/10/18","PMC5740328","","10.1128/AAC.01692-17"
"32477361","Evaluation of IL-1 Blockade as an Adjunct to Linezolid Therapy for Tuberculosis in Mice and Macaques","Winchell CG, Mishra BB, Phuah JY, Saqib M, Nelson SJ, Maiello P, Causgrove CM, Ameel CL, Stein B, Borish HJ, White AG, Klein EC, Zimmerman MD, Dartois V, Lin PL, Sassetti CM, Flynn JL.","Front Immunol. 2020 May 12;11:891. doi: 10.3389/fimmu.2020.00891. eCollection 2020.","Winchell CG","Front Immunol","2020","2020/06/02","PMC7235418","","10.3389/fimmu.2020.00891"
"35758754","Variants in Bedaquiline-Candidate-Resistance Genes: Prevalence in Bedaquiline-Naive Patients, Effect on MIC, and Association with Mycobacterium tuberculosis Lineage","Rivière E, Verboven L, Dippenaar A, Goossens S, De Vos E, Streicher E, Cuypers B, Laukens K, Ben-Rached F, Rodwell TC, Pain A, Warren RM, Heupink TH, Van Rie A.","Antimicrob Agents Chemother. 2022 Jul 19;66(7):e0032222. doi: 10.1128/aac.00322-22. Epub 2022 Jun 27.","Rivière E","Antimicrob Agents Chemother","2022","2022/06/27","PMC9295546","","10.1128/aac.00322-22"
"36892309","Emergence of Canonical and Noncanonical Genomic Variants following In Vitro Exposure of Clinical Mycobacterium tuberculosis Strains to Bedaquiline or Clofazimine","Ismail N, Dippenaar A, Warren RM, Peters RPH, Omar SV.","Antimicrob Agents Chemother. 2023 Apr 18;67(4):e0136822. doi: 10.1128/aac.01368-22. Epub 2023 Mar 9.","Ismail N","Antimicrob Agents Chemother","2023","2023/03/09","PMC10112258","","10.1128/aac.01368-22"
"30602509","Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis","Khalil ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, Hoang HN, Reiling N, Hillemann D, Brimble MA, Fairlie DP, Blumenthal A, Capon RJ.","Antimicrob Agents Chemother. 2019 Feb 26;63(3):e01773-18. doi: 10.1128/AAC.01773-18. Print 2019 Mar.","Khalil ZG","Antimicrob Agents Chemother","2019","2019/01/04","PMC6395912","","10.1128/AAC.01773-18"
"29941636","Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis","Rancoita PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, Hoosdally SJ, Walker TM, Grazian C, Davies TJ, Peto TEA, Crook DW, Fowler PW, Cirillo DM; CRyPTIC Consortiumfor the CRyPTIC Consortiumfor the CRyPTIC Consortium.","Antimicrob Agents Chemother. 2018 Aug 27;62(9):e00344-18. doi: 10.1128/AAC.00344-18. Print 2018 Sep.","Rancoita PMV","Antimicrob Agents Chemother","2018","2018/06/27","PMC6125532","","10.1128/AAC.00344-18"
"29712660","Novel Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus","Chen Y, Chen J, Zhang S, Shi W, Zhang W, Zhu M, Zhang Y.","Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00544-18. doi: 10.1128/AAC.00544-18. Print 2018 Jul.","Chen Y","Antimicrob Agents Chemother","2018","2018/05/02","PMC6021651","","10.1128/AAC.00544-18"
"29866874","Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay","de Miranda Silva C, Hajihosseini A, Myrick J, Nole J, Louie A, Schmidt S, Drusano GL.","Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00856-18. doi: 10.1128/AAC.00856-18. Print 2018 Aug.","de Miranda Silva C","Antimicrob Agents Chemother","2018","2018/06/06","PMC6105798","","10.1128/AAC.00856-18"
"35792049","High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates","Trisakul K, Nonghanphithak D, Chaiyachat P, Kaewprasert O, Sakmongkoljit K, Reechaipichitkul W, Chaiprasert A, Blair D, Clark TG, Faksri K.","Emerg Microbes Infect. 2022 Dec;11(1):1857-1866. doi: 10.1080/22221751.2022.2099304.","Trisakul K","Emerg Microbes Infect","2022","2022/07/06","PMC9336503","","10.1080/22221751.2022.2099304"
"33352041","Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity","Monakhova N, Korduláková J, Vocat A, Egorova A, Lepioshkin A, Salina EG, Nosek J, Repková E, Zemanová J, Jurdáková H, Górová R, Roh J, Degiacomi G, Sammartino JC, Pasca MR, Cole ST, Mikušová K, Makarov V.","ACS Infect Dis. 2021 Jan 8;7(1):88-100. doi: 10.1021/acsinfecdis.0c00622. Epub 2020 Dec 22.","Monakhova N","ACS Infect Dis","2021","2020/12/22","","","10.1021/acsinfecdis.0c00622"
"29458544","Antimicrobial activity against Mycobacterium tuberculosis under in vitro lipid-rich dormancy conditions","Aguilar-Ayala DA, Cnockaert M, Vandamme P, Palomino JC, Martin A, Gonzalez-Y-Merchand J.","J Med Microbiol. 2018 Mar;67(3):282-285. doi: 10.1099/jmm.0.000681. Epub 2018 Jan 15.","Aguilar-Ayala DA","J Med Microbiol","2018","2018/02/21","","","10.1099/jmm.0.000681"
"30818049","'Those who cannot remember the past are condemned to repeat it': Drug-susceptibility testing for bedaquiline and delamanid","Köser CU, Maurer FP, Kranzer K.","Int J Infect Dis. 2019 Mar;80S:S32-S35. doi: 10.1016/j.ijid.2019.02.027. Epub 2019 Feb 25.","Köser CU","Int J Infect Dis","2019","2019/03/01","","","10.1016/j.ijid.2019.02.027"
"31378263","Transcriptional profiling of a laboratory and clinical Mycobacterium tuberculosis strain suggests respiratory poisoning upon exposure to delamanid","Van den Bossche A, Varet H, Sury A, Sismeiro O, Legendre R, Coppee JY, Mathys V, Ceyssens PJ.","Tuberculosis (Edinb). 2019 Jul;117:18-23. doi: 10.1016/j.tube.2019.05.002. Epub 2019 May 15.","Van den Bossche A","Tuberculosis (Edinb)","2019","2019/08/06","","","10.1016/j.tube.2019.05.002"
"30027700","Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea","Yang JS, Kim KJ, Choi H, Lee SH.","Ann Lab Med. 2018 Nov;38(6):563-568. doi: 10.3343/alm.2018.38.6.563.","Yang JS","Ann Lab Med","2018","2018/07/21","PMC6056398","","10.3343/alm.2018.38.6.563"
"34782525","Linezolid-resistant Mycobacterium tuberculosis: Will it impact the tuberculosis elimination programme?","Bharadwaj R.","Indian J Med Res. 2021 Jul;154(1):16-18. doi: 10.4103/ijmr.IJMR_3537_20.","Bharadwaj R","Indian J Med Res","2021","2021/11/16","PMC8715697","","10.4103/ijmr.IJMR_3537_20"
"31285242","Insights into the Physiology and Metabolism of a Mycobacterial Cell in an Energy-Compromised State","Patil V, Jain V.","J Bacteriol. 2019 Sep 6;201(19):e00210-19. doi: 10.1128/JB.00210-19. Print 2019 Oct 1.","Patil V","J Bacteriol","2019","2019/07/10","PMC6755754","","10.1128/JB.00210-19"
"34780706","Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study","Ismail NA, Omar SV, Moultrie H, Bhyat Z, Conradie F, Enwerem M, Ferreira H, Hughes J, Joseph L, Kock Y, Letsaolo V, Maartens G, Meintjes G, Ngcamu D, Okozi N, Padanilam X, Reuter A, Romero R, Schaaf S, Te Riele J, Variava E, van der Meulen M, Ismail F, Ndjeka N.","Lancet Infect Dis. 2022 Apr;22(4):496-506. doi: 10.1016/S1473-3099(21)00470-9. Epub 2021 Nov 12.","Ismail NA","Lancet Infect Dis","2022","2021/11/15","","","10.1016/S1473-3099(21)00470-9"
"34302035","Laboratory evolution of Mycobacterium on agar plates for analysis of resistance acquisition and drug sensitivity profiles","Maeda T, Kawada M, Sakata N, Kotani H, Furusawa C.","Sci Rep. 2021 Jul 23;11(1):15136. doi: 10.1038/s41598-021-94645-z.","Maeda T","Sci Rep","2021","2021/07/24","PMC8302736","","10.1038/s41598-021-94645-z"
"36272707","Whole-genome sequencing of presumptive MDR-TB isolates from a tertiary healthcare setting in Mumbai","Zade A, Shah S, Hirani N, Kondabagil K, Joshi A, Chatterjee A.","J Glob Antimicrob Resist. 2022 Dec;31:256-262. doi: 10.1016/j.jgar.2022.10.004. Epub 2022 Oct 20.","Zade A","J Glob Antimicrob Resist","2022","2022/10/22","","","10.1016/j.jgar.2022.10.004"
"34280022","Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis","Yu W, Yusuf B, Wang S, Tian X, Hameed HMA, Lu Z, Chiwala G, Alam MS, Cook GM, Maslov DA, Zhong N, Zhang T.","Antimicrob Agents Chemother. 2021 Sep 17;65(10):e0070621. doi: 10.1128/AAC.00706-21. Epub 2021 Jul 19.","Yu W","Antimicrob Agents Chemother","2021","2021/07/19","PMC8448087","","10.1128/AAC.00706-21"
"32730621","Multidrug Resistant Tuberculosis With Simultaneously Acquired Drug Resistance to Bedaquiline and Delamanid","Yoshiyama T, Takaki A, Aono A, Mitarai S, Okumura M, Ohta K, Kato S.","Clin Infect Dis. 2021 Dec 16;73(12):2329-2331. doi: 10.1093/cid/ciaa1064.","Yoshiyama T","Clin Infect Dis","2021","2020/07/31","","","10.1093/cid/ciaa1064"
"36726220","Evaluating Truenat Assay for the Diagnosis of Ocular Tuberculosis and Detection of Drug Resistance","Sharma K, Sharma M, Ayyadurai N, Dogra M, Sharma A, Gupta V, Singh R, Gupta A.","Ocul Immunol Inflamm. 2023 Feb 1:1-7. doi: 10.1080/09273948.2023.2170888. Online ahead of print.","Sharma K","Ocul Immunol Inflamm","2023","2023/02/02","","","10.1080/09273948.2023.2170888"
"31981966","Triple Mycobacterial ATP-synthase mutations impedes Bedaquiline binding: Atomistic and structural perspectives","Salifu EY, Agoni C, Olotu FA, Soliman MES.","Comput Biol Chem. 2020 Apr;85:107204. doi: 10.1016/j.compbiolchem.2020.107204. Epub 2020 Jan 13.","Salifu EY","Comput Biol Chem","2020","2020/01/26","","","10.1016/j.compbiolchem.2020.107204"
"36855179","Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China","Hu Y, Fan J, Zhu D, Liu W, Li F, Li T, Zheng H.","Ann Clin Microbiol Antimicrob. 2023 Feb 28;22(1):19. doi: 10.1186/s12941-023-00568-0.","Hu Y","Ann Clin Microbiol Antimicrob","2023","2023/03/01","PMC9976417","","10.1186/s12941-023-00568-0"
"34570644","Comparative Efficacy of the Novel Diarylquinoline TBAJ-876 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis","Almeida D, Converse PJ, Li SY, Upton AM, Fotouhi N, Nuermberger EL.","Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0141221. doi: 10.1128/AAC.01412-21. Epub 2021 Sep 27.","Almeida D","Antimicrob Agents Chemother","2021","2021/09/27","PMC8597756","","10.1128/AAC.01412-21"
"30165087","In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants","Ismail N, Omar SV, Ismail NA, Peters RPH.","J Microbiol Methods. 2018 Oct;153:1-9. doi: 10.1016/j.mimet.2018.08.011. Epub 2018 Aug 28.","Ismail N","J Microbiol Methods","2018","2018/08/31","","","10.1016/j.mimet.2018.08.011"
"34796339","Genetic variants and their association with phenotypic resistance to bedaquiline in Mycobacterium tuberculosis: a systematic review and individual isolate data analysis","Ismail N, Rivière E, Limberis J, Huo S, Metcalfe JZ, Warren RM, Van Rie A.","Lancet Microbe. 2021 Nov;2(11):e604-e616. doi: 10.1016/s2666-5247(21)00175-0. Epub 2021 Aug 31.","Ismail N","Lancet Microbe","2021","2021/11/19","PMC8597953","NIHMS1753644","10.1016/s2666-5247(21)00175-0"
"35717636","Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis Treatment","Eimer J, Fréchet-Jachym M, Le Dû D, Caumes E, El-Helali N, Marigot-Outtandy D, Mechai F, Peytavin G, Pourcher V, Rioux C, Yazdanpanah Y, Robert J, Guglielmetti L; LZDM group.","Clin Infect Dis. 2023 Feb 8;76(3):e947-e956. doi: 10.1093/cid/ciac485.","Eimer J","Clin Infect Dis","2023","2022/06/19","","","10.1093/cid/ciac485"
"37154592","Molecular Epidemiology of Rifampicin-Resistant Mycobacterium tuberculosis by GeneXpert MTB/RIF Assay in Renal Transplant Recipients: A Single-Center Experience","Patel MH, Kanodia K, Nigam L, Patel R, Suthar K, Patel H, Kute V, Engineer D, Chauhan S, Meshram HS.","Exp Clin Transplant. 2023 Apr;21(4):317-323. doi: 10.6002/ect.2022.0408.","Patel MH","Exp Clin Transplant","2023","2023/05/08","","","10.6002/ect.2022.0408"
"33408221","Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis","Yamamoto K, Nakata N, Mukai T, Kawagishi I, Ato M.","mSphere. 2021 Jan 6;6(1):e00518-20. doi: 10.1128/mSphere.00518-20.","Yamamoto K","mSphere","2021","2021/01/07","PMC7845600","","10.1128/mSphere.00518-20"
"32474491","An overview of pulmonary infections due to rapidly growing mycobacteria in South Asia and impressions from a subtropical region","Shrivastava K, Kumar C, Singh A, Narang A, Giri A, Sharma NK, Gupta S, Chauhan V, Gunasekaran J, Balasubramanian V, Chaudhry A, Singla R, Prasad R, Varma-Basil M.","Int J Mycobacteriol. 2020 Jan-Mar;9(1):62-70. doi: 10.4103/ijmy.ijmy_179_19.","Shrivastava K","Int J Mycobacteriol","2020","2020/06/01","","","10.4103/ijmy.ijmy_179_19"
"35209842","Variants associated with Bedaquiline (BDQ) resistance identified in Rv0678 and efflux pump genes in Mycobacterium tuberculosis isolates from BDQ naïve TB patients in Pakistan","Saeed DK, Shakoor S, Razzak SA, Hasan Z, Sabzwari SF, Azizullah Z, Kanji A, Nasir A, Shafiq S, Ghanchi NK, Hasan R.","BMC Microbiol. 2022 Feb 25;22(1):62. doi: 10.1186/s12866-022-02475-4.","Saeed DK","BMC Microbiol","2022","2022/02/25","PMC8876534","","10.1186/s12866-022-02475-4"
"36010326","New RAPMYCOI Sensititre(TM) Antimicrobial Susceptibility Test for Atypical Rapidly Growing Mycobacteria (RGM)","Borek A, Zabost A, Głogowska A, Filipczak D, Augustynowicz-Kopeć E.","Diagnostics (Basel). 2022 Aug 15;12(8):1976. doi: 10.3390/diagnostics12081976.","Borek A","Diagnostics (Basel)","2022","2022/08/26","PMC9407062","","10.3390/diagnostics12081976"
"33986463","Bedaquiline, an FDA-approved drug, inhibits mitochondrial ATP production and metastasis in vivo, by targeting the gamma subunit (ATP5F1C) of the ATP synthase","Fiorillo M, Scatena C, Naccarato AG, Sotgia F, Lisanti MP.","Cell Death Differ. 2021 Sep;28(9):2797-2817. doi: 10.1038/s41418-021-00788-x. Epub 2021 May 13.","Fiorillo M","Cell Death Differ","2021","2021/05/14","PMC8408289","","10.1038/s41418-021-00788-x"
"33556430","Prevalence and molecular characterizations of seven additional drug resistance among multidrug-resistant tuberculosis in China: A subsequent study of a national survey","Wang G, Jiang G, Jing W, Zong Z, Yu X, Chen S, Li W, Huang H.","J Infect. 2021 Mar;82(3):371-377. doi: 10.1016/j.jinf.2021.02.004. Epub 2021 Feb 5.","Wang G","J Infect","2021","2021/02/08","","","10.1016/j.jinf.2021.02.004"
"33526488","Comparative Efficacy of the Novel Diarylquinoline TBAJ-587 and Bedaquiline against a Resistant Rv0678 Mutant in a Mouse Model of Tuberculosis","Xu J, Converse PJ, Upton AM, Mdluli K, Fotouhi N, Nuermberger EL.","Antimicrob Agents Chemother. 2021 Mar 18;65(4):e02418-20. doi: 10.1128/AAC.02418-20. Print 2021 Mar 18.","Xu J","Antimicrob Agents Chemother","2021","2021/02/02","PMC8097419","","10.1128/AAC.02418-20"
"36426362","Delamanid suppresses CXCL10 expression via regulation of JAK/STAT1 signaling and correlates with reduced inflammation in tuberculosis patients","Qiao M, Li S, Yuan J, Ren W, Shang Y, Wang W, Liu R, Zhang F, Li Q, Wu X, Lu J, Gao M, Pang Y.","Front Immunol. 2022 Nov 8;13:923492. doi: 10.3389/fimmu.2022.923492. eCollection 2022.","Qiao M","Front Immunol","2022","2022/11/25","PMC9679411","","10.3389/fimmu.2022.923492"
"35301246","Epidemiological cut-off values for a 96-well broth microdilution plate for high-throughput research antibiotic susceptibility testing of M. tuberculosis","CRyPTIC Consortium.","Eur Respir J. 2022 Oct 13;60(4):2200239. doi: 10.1183/13993003.00239-2022. Print 2022 Oct.","CRyPTIC Consortium","Eur Respir J","2022","2022/03/18","PMC9556810","EMS146260","10.1183/13993003.00239-2022"
"35261334","Drug resistance profiles and related gene mutations in slow-growing non-tuberculous mycobacteria isolated in regional tuberculosis reference laboratories of Iran: a three year cross-sectional study","Akrami S, Dokht Khosravi A, Hashemzadeh M.","Pathog Glob Health. 2023 Feb;117(1):52-62. doi: 10.1080/20477724.2022.2049029. Epub 2022 Mar 9.","Akrami S","Pathog Glob Health","2023","2022/03/09","PMC9848329","","10.1080/20477724.2022.2049029"
"36602336","Cyclic AMP-Mediated Inhibition of Cholesterol Catabolism in Mycobacterium tuberculosis by the Novel Drug Candidate GSK2556286","Brown KL, Wilburn KM, Montague CR, Grigg JC, Sanz O, Pérez-Herrán E, Barros D, Ballell L, VanderVen BC, Eltis LD.","Antimicrob Agents Chemother. 2023 Jan 24;67(1):e0129422. doi: 10.1128/aac.01294-22. Epub 2023 Jan 5.","Brown KL","Antimicrob Agents Chemother","2023","2023/01/05","PMC9872607","","10.1128/aac.01294-22"
"31141524","Empirical ways to identify novel Bedaquiline resistance mutations in AtpE","Karmakar M, Rodrigues CHM, Holt KE, Dunstan SJ, Denholm J, Ascher DB.","PLoS One. 2019 May 29;14(5):e0217169. doi: 10.1371/journal.pone.0217169. eCollection 2019.","Karmakar M","PLoS One","2019","2019/05/30","PMC6541270","","10.1371/journal.pone.0217169"
"36721630","Screening and Drug Resistance Analysis of Non-Tuberculous Mycobacteria in Patients with Suspected Pulmonary Tuberculosis on the Hainan Island, China","Wang J, Chen Z, Xu Y, Qiu W, Chen S, Pei H, Zhong Y.","Infect Drug Resist. 2023 Jan 25;16:463-476. doi: 10.2147/IDR.S396050. eCollection 2023.","Wang J","Infect Drug Resist","2023","2023/02/01","PMC9884444","","10.2147/IDR.S396050"
"35989319","High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region","Dreyer V, Mandal A, Dev P, Merker M, Barilar I, Utpatel C, Nilgiriwala K, Rodrigues C, Crook DW; CRyPTIC Consortium; Rasigade JP, Wirth T, Mistry N, Niemann S.","Genome Med. 2022 Aug 22;14(1):95. doi: 10.1186/s13073-022-01076-0.","Dreyer V","Genome Med","2022","2022/08/21","PMC9394022","","10.1186/s13073-022-01076-0"
"34090328","A high-throughput screening assay based on automated microscopy for monitoring antibiotic susceptibility of Mycobacterium tuberculosis phenotypes","Kalsum S, Andersson B, Das J, Schön T, Lerm M.","BMC Microbiol. 2021 Jun 5;21(1):167. doi: 10.1186/s12866-021-02212-3.","Kalsum S","BMC Microbiol","2021","2021/06/06","PMC8178828","","10.1186/s12866-021-02212-3"
"35920665","Mutations in rv0678 Confer Low-Level Resistance to Benzothiazinone DprE1 Inhibitors in Mycobacterium tuberculosis","Poulton NC, Azadian ZA, DeJesus MA, Rock JM.","Antimicrob Agents Chemother. 2022 Sep 20;66(9):e0090422. doi: 10.1128/aac.00904-22. Epub 2022 Aug 3.","Poulton NC","Antimicrob Agents Chemother","2022","2022/08/03","PMC9487612","","10.1128/aac.00904-22"
"30989745","Impact of bedaquiline and capreomycin on the gene expression patterns of multidrug-resistant Mycobacterium tuberculosis H37Rv strain and understanding the molecular mechanism of antibiotic resistance","Miryala SK, Anbarasu A, Ramaiah S.","J Cell Biochem. 2019 Sep;120(9):14499-14509. doi: 10.1002/jcb.28711. Epub 2019 Apr 15.","Miryala SK","J Cell Biochem","2019","2019/04/17","","","10.1002/jcb.28711"
"34878043","Putative extensive and pre-extensive drug resistant-tuberculosis associated with unusual genotypes on the Thailand-Myanmar border","Rudeeaneksin J, Klayut W, Srisungngam S, Bunchoo S, Toonkomdang S, Wongchai T, Chuenchom N, Phetsuksiri B.","Rev Inst Med Trop Sao Paulo. 2021 Dec 6;63:e85. doi: 10.1590/S1678-9946202163085. eCollection 2021.","Rudeeaneksin J","Rev Inst Med Trop Sao Paulo","2021","2021/12/08","PMC8660029","","10.1590/S1678-9946202163085"
"37268350","Bacterial and mammalian F(1)F(O)-ATPase: Structural similarities and divergences to exploit in the battle against Mycobacterium tuberculosis","Nesci S.","Int Rev Cell Mol Biol. 2023;377:45-63. doi: 10.1016/bs.ircmb.2023.01.006. Epub 2023 Feb 1.","Nesci S","Int Rev Cell Mol Biol","2023","2023/06/02","","","10.1016/bs.ircmb.2023.01.006"
"33239092","MDR M. tuberculosis outbreak clone in Eswatini missed by Xpert has elevated bedaquiline resistance dated to the pre-treatment era","Beckert P, Sanchez-Padilla E, Merker M, Dreyer V, Kohl TA, Utpatel C, Köser CU, Barilar I, Ismail N, Omar SV, Klopper M, Warren RM, Hoffmann H, Maphalala G, Ardizzoni E, de Jong BC, Kerschberger B, Schramm B, Andres S, Kranzer K, Maurer FP, Bonnet M, Niemann S.","Genome Med. 2020 Nov 25;12(1):104. doi: 10.1186/s13073-020-00793-8.","Beckert P","Genome Med","2020","2020/11/26","PMC7687760","","10.1186/s13073-020-00793-8"
"30249701","Coenzyme F(420)-Dependent Glucose-6-Phosphate Dehydrogenase-Coupled Polyglutamylation of Coenzyme F(420) in Mycobacteria","Purwantini E, Loganathan U, Mukhopadhyay B.","J Bacteriol. 2018 Nov 6;200(23):e00375-18. doi: 10.1128/JB.00375-18. Print 2018 Dec 1.","Purwantini E","J Bacteriol","2018","2018/09/26","PMC6222201","","10.1128/JB.00375-18"
"30029911","Mutations associated with in vitro resistance to bedaquiline in Mycobacterium tuberculosis isolates in Australia","Martinez E, Hennessy D, Jelfs P, Crighton T, Chen SC, Sintchenko V.","Tuberculosis (Edinb). 2018 Jul;111:31-34. doi: 10.1016/j.tube.2018.04.007. Epub 2018 Apr 25.","Martinez E","Tuberculosis (Edinb)","2018","2018/07/22","","","10.1016/j.tube.2018.04.007"
"32660992","A Multimethod, Multicountry Evaluation of Breakpoints for Bedaquiline Resistance Determination","Ismail NA, Aono A, Borroni E, Cirillo DM, Desmaretz C, Hasan R, Mitarai S, Shakoor S, Torrea G, Kaniga K, Omar SV.","Antimicrob Agents Chemother. 2020 Aug 20;64(9):e00479-20. doi: 10.1128/AAC.00479-20. Print 2020 Aug 20.","Ismail NA","Antimicrob Agents Chemother","2020","2020/07/15","PMC7449194","","10.1128/AAC.00479-20"
"32152081","Adduct Formation of Delamanid with NAD in Mycobacteria","Hayashi M, Nishiyama A, Kitamoto R, Tateishi Y, Osada-Oka M, Nishiuchi Y, Kaboso SA, Chen X, Fujiwara M, Inoue Y, Kawano Y, Kawasaki M, Abe T, Sato T, Kaneko K, Itoh K, Matsumoto S, Matsumoto M.","Antimicrob Agents Chemother. 2020 Apr 21;64(5):e01755-19. doi: 10.1128/AAC.01755-19. Print 2020 Apr 21.","Hayashi M","Antimicrob Agents Chemother","2020","2020/03/11","PMC7179590","","10.1128/AAC.01755-19"
"29760127","In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China","Luo J, Yu X, Jiang G, Fu Y, Huo F, Ma Y, Wang F, Shang Y, Liang Q, Xue Y, Huang H.","Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00072-18. doi: 10.1128/AAC.00072-18. Print 2018 Jul.","Luo J","Antimicrob Agents Chemother","2018","2018/05/16","PMC6021646","","10.1128/AAC.00072-18"
"32046149","Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of Mycobacterium Tuberculosis from Iran","Kardan-Yamchi J, Kazemian H, Battaglia S, Abtahi H, Foroushani AR, Hamzelou G, Cirillo DM, Ghodousi A, Feizabadi MM.","J Clin Med. 2020 Feb 7;9(2):465. doi: 10.3390/jcm9020465.","Kardan-Yamchi J","J Clin Med","2020","2020/02/13","PMC7073636","","10.3390/jcm9020465"
"29844043","Comparison of In Vitro Activity and MIC Distributions between the Novel Oxazolidinone Delpazolid and Linezolid against Multidrug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis in China","Zong Z, Jing W, Shi J, Wen S, Zhang T, Huo F, Shang Y, Liang Q, Huang H, Pang Y.","Antimicrob Agents Chemother. 2018 Jul 27;62(8):e00165-18. doi: 10.1128/AAC.00165-18. Print 2018 Aug.","Zong Z","Antimicrob Agents Chemother","2018","2018/05/31","PMC6105784","","10.1128/AAC.00165-18"
"32229496","OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor","Hariguchi N, Chen X, Hayashi Y, Kawano Y, Fujiwara M, Matsuba M, Shimizu H, Ohba Y, Nakamura I, Kitamoto R, Shinohara T, Uematsu Y, Ishikawa S, Itotani M, Haraguchi Y, Takemura I, Matsumoto M.","Antimicrob Agents Chemother. 2020 May 21;64(6):e02020-19. doi: 10.1128/AAC.02020-19. Print 2020 May 21.","Hariguchi N","Antimicrob Agents Chemother","2020","2020/04/02","PMC7269503","","10.1128/AAC.02020-19"
"33333664","[Antibiotic analysis and whole genome sequencing of two nocardia farcinica strains causing joint infection]","Wang H, Cheng F, Dong XT, Li XF, Wang YJ, Hao MJ.","Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Dec 6;54(12):1441-1447. doi: 10.3760/cma.j.cn112150-20200922-01226.","Wang H","Zhonghua Yu Fang Yi Xue Za Zhi","2020","2020/12/17","","","10.3760/cma.j.cn112150-20200922-01226"
"29860815","[Identification and drug susceptibility testing of Mycobacterium thermoresistibile and Mycobacterium elephantis isolated from a cow with mastitis]","Li WB, Ji LY, Xu DL, Liu HC, Zhao XQ, Wu YM, Wan KL.","Zhonghua Liu Xing Bing Xue Za Zhi. 2018 May 10;39(5):669-672. doi: 10.3760/cma.j.issn.0254-6450.2018.05.025.","Li WB","Zhonghua Liu Xing Bing Xue Za Zhi","2018","2018/06/05","","","10.3760/cma.j.issn.0254-6450.2018.05.025"
"32430409","Cellular and Structural Basis of Synthesis of the Unique Intermediate Dehydro-F(420)-0 in Mycobacteria","Grinter R, Ney B, Brammananth R, Barlow CK, Cordero PRF, Gillett DL, Izoré T, Cryle MJ, Harold LK, Cook GM, Taiaroa G, Williamson DA, Warden AC, Oakeshott JG, Taylor MC, Crellin PK, Jackson CJ, Schittenhelm RB, Coppel RL, Greening C.","mSystems. 2020 May 19;5(3):e00389-20. doi: 10.1128/mSystems.00389-20.","Grinter R","mSystems","2020","2020/05/21","PMC7253369","","10.1128/mSystems.00389-20"
"35352097","Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis","Bateman M, Wolf A, Chimukangara B, Brust JCM, Lessells R, Amico R, Boodhram R, Singh N, Orrell C, Friedland G, Naidoo K, Padayatchi N, O'Donnell MR.","Clin Infect Dis. 2022 Oct 29;75(9):1489-1496. doi: 10.1093/cid/ciac232.","Bateman M","Clin Infect Dis","2022","2022/03/30","PMC9617578","","10.1093/cid/ciac232"
"36296721","A Hydrazine-Hydrazone Adamantine Compound Shows Antimycobacterial Activity and Is a Probable Inhibitor of MmpL3","Briffotaux J, Xu Y, Huang W, Hui Z, Wang X, Gicquel B, Liu S.","Molecules. 2022 Oct 21;27(20):7130. doi: 10.3390/molecules27207130.","Briffotaux J","Molecules","2022","2022/10/27","PMC9610904","","10.3390/molecules27207130"
"35964846","Diagnostic Capacities for Multidrug-Resistant Tuberculosis in the World Health Organization European Region: Action is Needed by all Member States","Maurer FP, Shubladze N, Kalmambetova G, Felker I, Kuchukhidze G, Köser CU, Cirillo DM, Drobniewski F, Yedilbayev A, Ehsani S; European Laboratory Initiative on TB, HIV and Viral Hepatitis.","J Mol Diagn. 2022 Nov;24(11):1189-1194. doi: 10.1016/j.jmoldx.2022.07.005. Epub 2022 Aug 11.","Maurer FP","J Mol Diagn","2022","2022/08/14","","","10.1016/j.jmoldx.2022.07.005"
"32014024","A landscape of genomic alterations at the root of a near-untreatable tuberculosis epidemic","Klopper M, Heupink TH, Hill-Cawthorne G, Streicher EM, Dippenaar A, de Vos M, Abdallah AM, Limberis J, Merker M, Burns S, Niemann S, Dheda K, Posey J, Pain A, Warren RM.","BMC Med. 2020 Feb 4;18(1):24. doi: 10.1186/s12916-019-1487-2.","Klopper M","BMC Med","2020","2020/02/05","PMC6998097","","10.1186/s12916-019-1487-2"
"31417530","Evaluation of Whole-Genome Sequence Method to Diagnose Resistance of 13 Anti-tuberculosis Drugs and Characterize Resistance Genes in Clinical Multi-Drug Resistance Mycobacterium tuberculosis Isolates From China","Chen X, He G, Wang S, Lin S, Chen J, Zhang W.","Front Microbiol. 2019 Jul 31;10:1741. doi: 10.3389/fmicb.2019.01741. eCollection 2019.","Chen X","Front Microbiol","2019","2019/08/17","PMC6685394","","10.3389/fmicb.2019.01741"
"31097068","Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing","Ismail NA, Said HM, Rodrigues C, Omar SV, Ajbani K, Sukhadiad N, Kohl TA, Niemann S, Kranzer K, Diels M, Rigouts L, Rüsch-Gerdes S, Siddiqi S.","Int J Tuberc Lung Dis. 2019 May 1;23(5):594-599. doi: 10.5588/ijtld.18.0417.","Ismail NA","Int J Tuberc Lung Dis","2019","2019/05/18","","","10.5588/ijtld.18.0417"
"35195572","Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS","O'Donnell MR, Padayatchi N, Wolf A, Zelnick J, Daftary A, Orrell C, Nimmo C, Baldwin M, Boodhram R, Maharaj B, Amico KR, Naidoo K, Friedland G.","J Acquir Immune Defic Syndr. 2022 Jul 1;90(3):325-332. doi: 10.1097/QAI.0000000000002940.","O'Donnell MR","J Acquir Immune Defic Syndr","2022","2022/02/23","","","10.1097/QAI.0000000000002940"
"32814813","Bedaquiline inhibits the yeast and human mitochondrial ATP synthases","Luo M, Zhou W, Patel H, Srivastava AP, Symersky J, Bonar MM, Faraldo-Gómez JD, Liao M, Mueller DM.","Commun Biol. 2020 Aug 19;3(1):452. doi: 10.1038/s42003-020-01173-z.","Luo M","Commun Biol","2020","2020/08/21","PMC7438494","","10.1038/s42003-020-01173-z"
"35650698","Impact of Rv0678 mutations on patients with drug-resistant TB treated with bedaquiline","Kaniga K, Lounis N, Zhuo S, Bakare N, Andries K.","Int J Tuberc Lung Dis. 2022 Jun 1;26(6):571-573. doi: 10.5588/ijtld.21.0670.","Kaniga K","Int J Tuberc Lung Dis","2022","2022/06/02","PMC9165736","","10.5588/ijtld.21.0670"
"37180636","Epidemiology of Nontuberculous Mycobacteria in Nanjing and MAB_0540 Mutations Associated with Clofazimine Resistance in Mycobacterium abscessus","Zhang R, Luo S, Wang N, Zhang H, Wu X.","Infect Drug Resist. 2023 May 6;16:2751-2764. doi: 10.2147/IDR.S408986. eCollection 2023.","Zhang R","Infect Drug Resist","2023","2023/05/14","PMC10171220","","10.2147/IDR.S408986"
"30478161","Molecular Analysis of Linezolid-Resistant Clinical Isolates of Mycobacterium abscessus","Ye M, Xu L, Zou Y, Li B, Guo Q, Zhang Y, Zhan M, Xu B, Yu F, Zhang Z, Chu H.","Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01842-18. doi: 10.1128/AAC.01842-18. Print 2019 Feb.","Ye M","Antimicrob Agents Chemother","2019","2018/11/28","PMC6355594","","10.1128/AAC.01842-18"
"34053953","Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China","Li J, Shen H, Yu T, Tao XY, Hu YM, Wang HC, Zou MX.","Jpn J Infect Dis. 2022 Jan 24;75(1):31-35. doi: 10.7883/yoken.JJID.2020.1096. Epub 2021 May 31.","Li J","Jpn J Infect Dis","2022","2021/05/31","","","10.7883/yoken.JJID.2020.1096"
"32474547","Mutation in atpE and Rv0678 genes associated with bedaquline resistance among drug-resistant tuberculosis patients: A pilot study from a high-burden setting in Northern India","Singh BK, Soneja M, Sharma R, Chaubey J, Kodan P, Jorwal P, Nischal N, Chandra S, Ramachandran R, Wig N.","Int J Mycobacteriol. 2020 Apr-Jun;9(2):212-215. doi: 10.4103/ijmy.ijmy_30_20.","Singh BK","Int J Mycobacteriol","2020","2020/06/01","","","10.4103/ijmy.ijmy_30_20"
"31332077","The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus","Gutiérrez AV, Richard M, Roquet-Banères F, Viljoen A, Kremer L.","Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01000-19. doi: 10.1128/AAC.01000-19. Print 2019 Oct.","Gutiérrez AV","Antimicrob Agents Chemother","2019","2019/07/24","PMC6761555","","10.1128/AAC.01000-19"
"32803174","Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis","Nimmo C, Millard J, van Dorp L, Brien K, Moodley S, Wolf A, Grant AD, Padayatchi N, Pym AS, Balloux F, O'Donnell M.","Lancet Microbe. 2020 Aug;1(4):e165-e174. doi: 10.1016/S2666-5247(20)30031-8.","Nimmo C","Lancet Microbe","2020","2020/08/18","PMC7416634","","10.1016/S2666-5247(20)30031-8"
"32724033","[The tuberculosis in 2020: challenges and opportunities.]","García Pérez FJ, Ancochea Bermúdez J.","Rev Esp Salud Publica. 2020 Jul 29;94:e202007090.","García Pérez FJ","Rev Esp Salud Publica","2020","2020/07/30","","",""
"34287057","Intragenic Distribution of IS6110 in Clinical Mycobacterium tuberculosis Strains: Bioinformatic Evidence for Gene Disruption Leading to Underdiagnosed Antibiotic Resistance","Antoine R, Gaudin C, Hartkoorn RC.","Microbiol Spectr. 2021 Sep 3;9(1):e0001921. doi: 10.1128/Spectrum.00019-21. Epub 2021 Jul 21.","Antoine R","Microbiol Spectr","2021","2021/07/21","PMC8552512","","10.1128/Spectrum.00019-21"
"36418994","Bedaquiline resistance probability to guide treatment decision making for rifampicin-resistant tuberculosis: insights from a qualitative study","Tu PHT, Anlay DZ, Dippenaar A, Conceição EC, Loos J, Van Rie A.","BMC Infect Dis. 2022 Nov 22;22(1):876. doi: 10.1186/s12879-022-07865-7.","Tu PHT","BMC Infect Dis","2022","2022/11/24","PMC9682818","","10.1186/s12879-022-07865-7"
"35596983","In vitro activity of tedizolid and linezolid against multidrug-resistant Mycobacterium tuberculosis: a comparative study using microdilution broth assay and genomics","Aono A, Murase Y, Chikamatsu K, Igarashi Y, Shimomura Y, Hosoya M, Osugi A, Morishige Y, Takaki A, Yamada H, Mitarai S.","Diagn Microbiol Infect Dis. 2022 Jul;103(3):115714. doi: 10.1016/j.diagmicrobio.2022.115714. Epub 2022 Apr 22.","Aono A","Diagn Microbiol Infect Dis","2022","2022/05/21","","","10.1016/j.diagmicrobio.2022.115714"
"31229592","Acquisition of bedaquiline resistance by extensively drug-resistant Mycobacterium tuberculosis strain of Central Asian Outbreak clade","Mokrousov I, Akhmedova G, Polev D, Molchanov V, Vyazovaya A.","Clin Microbiol Infect. 2019 Oct;25(10):1295-1297. doi: 10.1016/j.cmi.2019.06.014. Epub 2019 Jun 20.","Mokrousov I","Clin Microbiol Infect","2019","2019/06/24","","","10.1016/j.cmi.2019.06.014"
"29712658","Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus","Li B, Ye M, Guo Q, Zhang Z, Yang S, Ma W, Yu F, Chu H.","Antimicrob Agents Chemother. 2018 Jun 26;62(7):e00175-18. doi: 10.1128/AAC.00175-18. Print 2018 Jul.","Li B","Antimicrob Agents Chemother","2018","2018/05/02","PMC6021634","","10.1128/AAC.00175-18"
"33717055","Submission for Special Issue: The Role of Platelet Activation in the Pathophysiology of HIV, Tuberculosis, and Pneumococcal Disease. Bedaquiline Suppresses ADP-Mediated Activation of Human Platelets In Vitro via Interference With Phosphatidylinositol 3-Kinase","Tintinger GR, Theron AJ, Steel HC, Cholo MC, Nel JG, Feldman C, Anderson R.","Front Immunol. 2021 Feb 26;11:621148. doi: 10.3389/fimmu.2020.621148. eCollection 2020.","Tintinger GR","Front Immunol","2021","2021/03/15","PMC7952968","","10.3389/fimmu.2020.621148"
"32053752","Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon","Andres S, Merker M, Heyckendorf J, Kalsdorf B, Rumetshofer R, Indra A, Hofmann-Thiel S, Hoffmann H, Lange C, Niemann S, Maurer FP.","Am J Respir Crit Care Med. 2020 Jun 15;201(12):1564-1568. doi: 10.1164/rccm.201909-1819LE.","Andres S","Am J Respir Crit Care Med","2020","2020/02/14","","","10.1164/rccm.201909-1819LE"
"31121229","Structure based identification of novel inhibitors against ATP synthase of Mycobacterium tuberculosis: A combined in silico and in vitro study","Shahbaaz M, Cloete R, Grobbelaar M, Sampson S, Christoffels A.","Int J Biol Macromol. 2019 Aug 15;135:582-590. doi: 10.1016/j.ijbiomac.2019.05.108. Epub 2019 May 20.","Shahbaaz M","Int J Biol Macromol","2019","2019/05/24","","","10.1016/j.ijbiomac.2019.05.108"
"29996350","[Antimicrobial susceptibility and genotyping of Mycobacterium intracellulare]","Wang SQ, Jiang GL, Wei GM, Huo FM, Dong LL, Zhao LP, Huang HR, Wang GR.","Zhonghua Jie He He Hu Xi Za Zhi. 2018 Jul 12;41(7):539-543. doi: 10.3760/cma.j.issn.1001-0939.2018.07.007.","Wang SQ","Zhonghua Jie He He Hu Xi Za Zhi","2018","2018/07/12","","","10.3760/cma.j.issn.1001-0939.2018.07.007"
"35946941","Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus","Wang S, Cai X, Yu W, Zeng S, Zhang J, Guo L, Gao Y, Lu Z, Hameed HMA, Fang C, Tian X, Yusuf B, Chhotaray C, Alam MDS, Zhang B, Ge H, Maslov DA, Cook GM, Peng J, Lin Y, Zhong N, Zhang G, Zhang T.","Microbiol Spectr. 2022 Aug 31;10(4):e0276321. doi: 10.1128/spectrum.02763-21. Epub 2022 Aug 10.","Wang S","Microbiol Spectr","2022","2022/08/10","PMC9430846","","10.1128/spectrum.02763-21"
"31974497","Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing","Ismail NA, Ismail F, Joseph L, Govender N, Blows L, Kaniga K, Omar SV.","Sci Rep. 2020 Jan 23;10(1):1013. doi: 10.1038/s41598-020-57992-x.","Ismail NA","Sci Rep","2020","2020/01/25","PMC6978314","","10.1038/s41598-020-57992-x"
"37315052","A Bayesian approach to estimate the probability of resistance to bedaquiline in the presence of a genomic variant","Anlay DZ, Rivière E, Tu PHT, Abrams S, Van Rie A.","PLoS One. 2023 Jun 14;18(6):e0287019. doi: 10.1371/journal.pone.0287019. eCollection 2023.","Anlay DZ","PLoS One","2023","2023/06/14","PMC10266631","","10.1371/journal.pone.0287019"
"32958720","Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models?","Drusano GL, Duncanson B, Scanga CA, Kim S, Schmidt S, Neely MN, Yamada WM, Vicchiarelli M, Peloquin CA, Louie A.","Antimicrob Agents Chemother. 2020 Nov 17;64(12):e01376-20. doi: 10.1128/AAC.01376-20. Print 2020 Nov 17.","Drusano GL","Antimicrob Agents Chemother","2020","2020/09/22","PMC7674066","","10.1128/AAC.01376-20"
"30602521","High Prevalence of Bedaquiline Resistance in Treatment-Naive Tuberculosis Patients and Verapamil Effectiveness","Ghajavand H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, Masoumi M, Rahimi Jamnani F, Fateh A, Siadat SD, Vaziri F.","Antimicrob Agents Chemother. 2019 Feb 26;63(3):e02530-18. doi: 10.1128/AAC.02530-18. Print 2019 Mar.","Ghajavand H","Antimicrob Agents Chemother","2019","2019/01/04","PMC6395892","","10.1128/AAC.02530-18"
"31262763","Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in Mycobacterium abscessus","Ruth MM, van Rossum M, Koeken VACM, Pennings LJ, Svensson EM, Ruesen C, Bowles EC, Wertheim HFL, Hoefsloot W, van Ingen J.","Antimicrob Agents Chemother. 2019 Aug 23;63(9):e00449-19. doi: 10.1128/AAC.00449-19. Print 2019 Sep.","Ruth MM","Antimicrob Agents Chemother","2019","2019/07/03","PMC6709478","","10.1128/AAC.00449-19"
"33436128","Species identification and antimicrobial susceptibility testing of non-tuberculous mycobacteria isolated in Chongqing, Southwest China","Zhang H, Luo M, Zhang K, Yang X, Hu K, Fu Z, Zhang L, Wu P, Wan D, Han M, Wang X.","Epidemiol Infect. 2020 Dec 28;149:e7. doi: 10.1017/S0950268820003088.","Zhang H","Epidemiol Infect","2020","2021/01/13","PMC8057515","","10.1017/S0950268820003088"
"30212394","Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa","Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, OʼDonnell MR.","J Acquir Immune Defic Syndr. 2018 Dec 1;79(4):474-480. doi: 10.1097/QAI.0000000000001833.","Yuengling KA","J Acquir Immune Defic Syndr","2018","2018/09/14","PMC6203657","NIHMS1502279","10.1097/QAI.0000000000001833"
"35916253","Mycobacterium paragordonae is an emerging pathogen in human pulmonary disease: clinical features, antimicrobial susceptibility testing and outcomes","Li Y, Zhang W, Zhao J, Lai W, Zhao Y, Li Y, Qu J.","Emerg Microbes Infect. 2022 Dec;11(1):1973-1981. doi: 10.1080/22221751.2022.2103453.","Li Y","Emerg Microbes Infect","2022","2022/08/02","PMC9364734","","10.1080/22221751.2022.2103453"
"36002805","Evaluation of the broth microdilution plate methodology for susceptibility testing of Mycobacterium tuberculosis in Peru","Puyén ZM, Santos-Lázaro D, Vigo AN, Coronel J, Alarcón MJ, Cotrina VV, Moore DAJ.","BMC Infect Dis. 2022 Aug 24;22(1):705. doi: 10.1186/s12879-022-07677-9.","Puyén ZM","BMC Infect Dis","2022","2022/08/24","PMC9399989","","10.1186/s12879-022-07677-9"
"30325198","Rational design of coumarin derivatives as antituberculosis agents","Mali HM, Sabale SS, Degani MS, Borkute R, Choudhari AS, Sarkar D, Krishna VS, Sriram D.","Future Med Chem. 2018 Oct;10(20):2431-2444. doi: 10.4155/fmc-2018-0015. Epub 2018 Oct 16.","Mali HM","Future Med Chem","2018","2018/10/17","","","10.4155/fmc-2018-0015"
"31012313","Mce3R Stress-Resistance Pathway Is Vulnerable to Small-Molecule Targeting That Improves Tuberculosis Drug Activities","Yang X, Yuan T, Ma R, Chacko KI, Smith M, Deikus G, Sebra R, Kasarskis A, van Bakel H, Franzblau SG, Sampson NS.","ACS Infect Dis. 2019 Jul 12;5(7):1239-1251. doi: 10.1021/acsinfecdis.9b00099. Epub 2019 May 3.","Yang X","ACS Infect Dis","2019","2019/04/24","PMC6630528","","10.1021/acsinfecdis.9b00099"
"32890726","Emergence of nontuberculous mycobacteria infections during bedaquiline-containing regimens in multidrug-resistant tuberculosis patients","Gao J, Pei Y, Yan X, Shi G, Li T, Gao M, Liu Y, Wang Y, Shu W, Li L, Pang Y.","Int J Infect Dis. 2020 Nov;100:196-198. doi: 10.1016/j.ijid.2020.08.080. Epub 2020 Sep 2.","Gao J","Int J Infect Dis","2020","2020/09/05","","","10.1016/j.ijid.2020.08.080"
"31266866","mRNA Degradation Rates Are Coupled to Metabolic Status in Mycobacterium smegmatis","Vargas-Blanco DA, Zhou Y, Zamalloa LG, Antonelli T, Shell SS.","mBio. 2019 Jul 2;10(4):e00957-19. doi: 10.1128/mBio.00957-19.","Vargas-Blanco DA","mBio","2019","2019/07/04","PMC6606801","","10.1128/mBio.00957-19"
"34878300","Minimum Inhibitory Concentrations before and after Antibacterial Treatment in Patients with Mycobacterium abscessus Pulmonary Disease","Fujiwara K, Uesugi F, Furuuchi K, Tanaka Y, Yoshiyama T, Saotome M, Ohta K, Mitarai S, Morimoto K.","Microbiol Spectr. 2021 Dec 22;9(3):e0192821. doi: 10.1128/Spectrum.01928-21. Epub 2021 Dec 8.","Fujiwara K","Microbiol Spectr","2021","2021/12/08","PMC8653840","","10.1128/Spectrum.01928-21"
"31824511","Harnessing the Immunomodulatory Properties of Bacterial Ghosts to Boost the Anti-mycobacterial Protective Immunity","Lim J, Koh VHQ, Cho SSL, Periaswamy B, Choi DPS, Vacca M, De Sessions PF, Kudela P, Lubitz W, Pastorin G, Alonso S.","Front Immunol. 2019 Nov 22;10:2737. doi: 10.3389/fimmu.2019.02737. eCollection 2019.","Lim J","Front Immunol","2019","2019/12/12","PMC6883722","","10.3389/fimmu.2019.02737"
"33805837","The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG","Cahill C, O'Connell F, Gogan KM, Cox DJ, Basdeo SA, O'Sullivan J, Gordon SV, Keane J, Phelan JJ.","Int J Mol Sci. 2021 Mar 13;22(6):2938. doi: 10.3390/ijms22062938.","Cahill C","Int J Mol Sci","2021","2021/04/03","PMC8001338","","10.3390/ijms22062938"
"32971422","A pilot RNA-seq study in 40 pietrain ejaculates to characterize the porcine sperm microbiome","Gòdia M, Ramayo-Caldas Y, Zingaretti LM, Darwich L, López S, Rodríguez-Gil JE, Yeste M, Sánchez A, Clop A.","Theriogenology. 2020 Nov;157:525-533. doi: 10.1016/j.theriogenology.2020.08.001. Epub 2020 Aug 15.","Gòdia M","Theriogenology","2020","2020/09/24","","","10.1016/j.theriogenology.2020.08.001"
"34445951","Emerging MDR-Mycobacterium avium subsp. avium in house-reared domestic birds as the first report in Egypt","Algammal AM, Hashem HR, Al-Otaibi AS, Alfifi KJ, El-Dawody EM, Mahrous E, Hetta HF, El-Kholy AW, Ramadan H, El-Tarabili RM.","BMC Microbiol. 2021 Aug 26;21(1):237. doi: 10.1186/s12866-021-02287-y.","Algammal AM","BMC Microbiol","2021","2021/08/27","PMC8393820","","10.1186/s12866-021-02287-y"
"31910878","Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China","Xia H, van den Hof S, Cobelens F, Zhou Y, Zhao B, Wang S, Zhao Y.","BMC Infect Dis. 2020 Jan 7;20(1):19. doi: 10.1186/s12879-020-4758-9.","Xia H","BMC Infect Dis","2020","2020/01/09","PMC6947908","","10.1186/s12879-020-4758-9"
"33596848","Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial","Weng T, Sun F, Li Y, Chen J, Chen X, Li R, Ge S, Zhao Y, Zhang W.","BMC Infect Dis. 2021 Feb 17;21(1):183. doi: 10.1186/s12879-021-05870-w.","Weng T","BMC Infect Dis","2021","2021/02/18","PMC7888137","","10.1186/s12879-021-05870-w"
"30342828","Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","Makhado NA, Matabane E, Faccin M, Pinçon C, Jouet A, Boutachkourt F, Goeminne L, Gaudin C, Maphalala G, Beckert P, Niemann S, Delvenne JC, Delmée M, Razwiedani L, Nchabeleng M, Supply P, de Jong BC, André E.","Lancet Infect Dis. 2018 Dec;18(12):1350-1359. doi: 10.1016/S1473-3099(18)30496-1. Epub 2018 Oct 18.","Makhado NA","Lancet Infect Dis","2018","2018/10/22","","","10.1016/S1473-3099(18)30496-1"
"33777679","Ultra-short-course and intermittent TB47-containing oral regimens produce stable cure against Buruli ulcer in a murine model and prevent the emergence of resistance for Mycobacterium ulcerans","Gao Y, Hameed HMA, Liu Y, Guo L, Fang C, Tian X, Liu Z, Wang S, Lu Z, Islam MM, Zhang T.","Acta Pharm Sin B. 2021 Mar;11(3):738-749. doi: 10.1016/j.apsb.2020.11.007. Epub 2020 Nov 13.","Gao Y","Acta Pharm Sin B","2021","2021/03/29","PMC7982501","","10.1016/j.apsb.2020.11.007"
"29108416","Chlorflavonin Targets Acetohydroxyacid Synthase Catalytic Subunit IlvB1 for Synergistic Killing of Mycobacterium tuberculosis","Rehberg N, Akone HS, Ioerger TR, Erlenkamp G, Daletos G, Gohlke H, Proksch P, Kalscheuer R.","ACS Infect Dis. 2018 Feb 9;4(2):123-134. doi: 10.1021/acsinfecdis.7b00055. Epub 2017 Nov 16.","Rehberg N","ACS Infect Dis","2018","2017/11/08","","","10.1021/acsinfecdis.7b00055"
"36523787","Novel oxazolidinones harbor potent in vitro activity against the clinical isolates of multidrug-resistant Mycobacterium tuberculosis in China","Wang C, Wang G, Huo F, Xue Y, Jia J, Dong L, Zhao L, Wang F, Huang H, Duan H.","Front Med (Lausanne). 2022 Nov 29;9:1067516. doi: 10.3389/fmed.2022.1067516. eCollection 2022.","Wang C","Front Med (Lausanne)","2022","2022/12/16","PMC9745032","","10.3389/fmed.2022.1067516"
"35574601","Molecular dynamic assisted investigation on impact of mutations in deazaflavin dependent nitroreductase against pretomanid: a computational study","Singh R, Shaheer M, Sobhia ME.","J Biomol Struct Dyn. 2023 Jul;41(10):4421-4443. doi: 10.1080/07391102.2022.2069156. Epub 2022 May 14.","Singh R","J Biomol Struct Dyn","2023","2022/05/16","","","10.1080/07391102.2022.2069156"
"32891766","Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment","Mokrousov I, Akhmedova G, Molchanov V, Fundovnaya E, Kozlova E, Ostankova Y, Semenov A, Maslennikova N, Leontev D, Zhuravlev V, Turkin E, Vyazovaya A.","Clin Microbiol Infect. 2021 Mar;27(3):478-480. doi: 10.1016/j.cmi.2020.08.030. Epub 2020 Sep 3.","Mokrousov I","Clin Microbiol Infect","2021","2020/09/06","","","10.1016/j.cmi.2020.08.030"
"35898335","Integrative analysis of clinical health records, imaging and pathogen genomics identifies personalized predictors of disease prognosis in tuberculosis","Sambarey A, Smith K, Chung C, Arora HS, Yang Z, Agarwal P, Chandrasekaran S.","medRxiv. 2022 Jul 21:2022.07.20.22277862. doi: 10.1101/2022.07.20.22277862. Preprint.","Sambarey A","medRxiv","2022","2022/07/28","PMC9327630","","10.1101/2022.07.20.22277862"
"29712875","Roles of Alanine Dehydrogenase and Induction of Its Gene in Mycobacterium smegmatis under Respiration-Inhibitory Conditions","Jeong JA, Park SW, Yoon D, Kim S, Kang HY, Oh JI.","J Bacteriol. 2018 Jun 25;200(14):e00152-18. doi: 10.1128/JB.00152-18. Print 2018 Jul 15.","Jeong JA","J Bacteriol","2018","2018/05/02","PMC6018359","","10.1128/JB.00152-18"
"35203542","Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study","Shahbaaz M, Maslov DA, Vatlin AA, Danilenko VN, Grishina M, Christoffels A.","Biomedicines. 2022 Jan 31;10(2):333. doi: 10.3390/biomedicines10020333.","Shahbaaz M","Biomedicines","2022","2022/02/25","PMC8869396","","10.3390/biomedicines10020333"
"34785916","In vitro Antimicrobial Activity Comparison of Linezolid, Tedizolid, Sutezolid and Delpazolid Against Slowly Growing Mycobacteria Isolated in Beijing, China","Yu X, Huo F, Wang F, Wen S, Jiang G, Xue Y, Dong L, Zhao L, Zhu R, Huang H.","Infect Drug Resist. 2021 Nov 9;14:4689-4697. doi: 10.2147/IDR.S332835. eCollection 2021.","Yu X","Infect Drug Resist","2021","2021/11/17","PMC8590452","","10.2147/IDR.S332835"
"30390733","A Case of Generalized, Superinfected Dermatitis and Inguinal Mycobacterium Lymphadenitis - TB or not TB?","Rotaru M, Marchian S, Fekete GL, Mariana Iancu GM.","Acta Dermatovenerol Croat. 2018 Oct;26(3):270-272.","Rotaru M","Acta Dermatovenerol Croat","2018","2018/11/05","","",""
"35944069","A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics","The CRyPTIC Consortium.","PLoS Biol. 2022 Aug 9;20(8):e3001721. doi: 10.1371/journal.pbio.3001721. eCollection 2022 Aug.","The CRyPTIC Consortium","PLoS Biol","2022","2022/08/09","PMC9363010","","10.1371/journal.pbio.3001721"
"32448204","Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report","Erber J, Weidlich S, Tschaikowsky T, Rothe K, Schmid RM, Schneider J, Spinner CD.","BMC Infect Dis. 2020 May 24;20(1):365. doi: 10.1186/s12879-020-05075-7.","Erber J","BMC Infect Dis","2020","2020/05/26","PMC7245858","","10.1186/s12879-020-05075-7"
"31635590","Prevalence of isoniazid resistance-conferring mutations associated with multidrug-resistant tuberculosis in Free State Province, South Africa","Pitso L, Potgieter S, Van der Spoel van Dijk A.","S Afr Med J. 2019 Aug 28;109(9):659-664. doi: 10.7196/SAMJ.2019.v109i9.13730.","Pitso L","S Afr Med J","2019","2019/10/23","","","10.7196/SAMJ.2019.v109i9.13730"
"31599569","Naturally-Occurring Polymorphisms in QcrB Are Responsible for Resistance to Telacebec in Mycobacterium abscessus","Sorayah R, Manimekalai MSS, Shin SJ, Koh WJ, Grüber G, Pethe K.","ACS Infect Dis. 2019 Dec 13;5(12):2055-2060. doi: 10.1021/acsinfecdis.9b00322. Epub 2019 Oct 14.","Sorayah R","ACS Infect Dis","2019","2019/10/11","","","10.1021/acsinfecdis.9b00322"
"37123664","Knowledge, Attitude, and Practices Among Healthcare Practitioners in the Context of Multidrug Resistance Tuberculosis: An Appraisal to Disease Elimination","Jain M, Rath S, Mohanty M Sr, Mishra B, Mohapatra PR.","Cureus. 2023 Mar 28;15(3):e36788. doi: 10.7759/cureus.36788. eCollection 2023 Mar.","Jain M","Cureus","2023","2023/05/01","PMC10134086","","10.7759/cureus.36788"
"30496456","Multiparameter Responses to Tedizolid Monotherapy and Moxifloxacin Combination Therapy Models of Children With Intracellular Tuberculosis","Deshpande D, Srivastava S, Nuermberger E, Koeuth T, Martin KR, Cirrincione KN, Lee PS, Gumbo T.","Clin Infect Dis. 2018 Nov 28;67(suppl_3):S342-S348. doi: 10.1093/cid/ciy612.","Deshpande D","Clin Infect Dis","2018","2018/11/30","PMC6260150","","10.1093/cid/ciy612"
"36438838","2,4-Disubstituted pyridine derivatives are effective against intracellular and biofilm-forming tubercle bacilli","Korycka-Machała M, Kawka M, Lach J, Płocińska R, Bekier A, Dziadek B, Brzostek A, Płociński P, Strapagiel D, Szczesio M, Gobis K, Dziadek J.","Front Pharmacol. 2022 Nov 10;13:1004632. doi: 10.3389/fphar.2022.1004632. eCollection 2022.","Korycka-Machała M","Front Pharmacol","2022","2022/11/28","PMC9685343","","10.3389/fphar.2022.1004632"
"31705996","Bacillus Calmette-Guérin strains with defined resistance mutations: a new tool for tuberculosis laboratory quality control","Danchuk SN, McIntosh F, Jamieson FB, May K, Behr MA.","Clin Microbiol Infect. 2020 Mar;26(3):384.e5-384.e8. doi: 10.1016/j.cmi.2019.10.033. Epub 2019 Nov 6.","Danchuk SN","Clin Microbiol Infect","2020","2019/11/10","","","10.1016/j.cmi.2019.10.033"
"31312308","[Multidrug-resistant extrapulmonary tuberculosis: about 7 cases]","Haddaoui H, Mrabet FZ, Aharmim M, Bourkadi JE.","Pan Afr Med J. 2019 Apr 23;32:196. doi: 10.11604/pamj.2019.32.196.17995. eCollection 2019.","Haddaoui H","Pan Afr Med J","2019","2019/07/18","PMC6620082","","10.11604/pamj.2019.32.196.17995"
"32310272","Clofazimine, a Promising Drug for the Treatment of Babesia microti Infection in Severely Immunocompromised Hosts","Tuvshintulga B, Vannier E, Tayebwa DS, Gantuya S, Sivakumar T, Guswanto A, Krause PJ, Yokoyama N, Igarashi I.","J Infect Dis. 2020 Aug 17;222(6):1027-1036. doi: 10.1093/infdis/jiaa195.","Tuvshintulga B","J Infect Dis","2020","2020/04/21","","","10.1093/infdis/jiaa195"
"31138569","In Vitro Study of Stepwise Acquisition of rv0678 and atpE Mutations Conferring Bedaquiline Resistance","Ismail N, Ismail NA, Omar SV, Peters RPH.","Antimicrob Agents Chemother. 2019 Jul 25;63(8):e00292-19. doi: 10.1128/AAC.00292-19. Print 2019 Aug.","Ismail N","Antimicrob Agents Chemother","2019","2019/05/30","PMC6658778","","10.1128/AAC.00292-19"
"31526604","Synthesis and evaluation of a novel quinoline-triazole analogs for antitubercular properties via molecular hybridization approach","Ramprasad J, Kumar Sthalam V, Linga Murthy Thampunuri R, Bhukya S, Ummanni R, Balasubramanian S, Pabbaraja S.","Bioorg Med Chem Lett. 2019 Oct 15;29(20):126671. doi: 10.1016/j.bmcl.2019.126671. Epub 2019 Sep 5.","Ramprasad J","Bioorg Med Chem Lett","2019","2019/09/19","","","10.1016/j.bmcl.2019.126671"
"35550867","A case of primary multidrug-resistant pulmonary tuberculosis with high minimum inhibitory concentration value for bedaquiline","Kobayashi M, Motoki Y, Yamagishi T, Hirano H, Nonaka M, Aono A, Mitarai S, Saito T.","J Infect Chemother. 2022 Aug;28(8):1193-1197. doi: 10.1016/j.jiac.2022.04.028. Epub 2022 May 10.","Kobayashi M","J Infect Chemother","2022","2022/05/13","","","10.1016/j.jiac.2022.04.028"
"33536294","Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania","Mbelele PM, Mpolya EA, Sauli E, Mtafya B, Ntinginya NE, Addo KK, Kreppel K, Mfinanga S, Phillips PPJ, Gillespie SH, Heysell SK, Sabiiti W, Mpagama SG.","J Clin Microbiol. 2021 Mar 19;59(4):e02927-20. doi: 10.1128/JCM.02927-20. Print 2021 Mar 19.","Mbelele PM","J Clin Microbiol","2021","2021/02/04","PMC8092737","","10.1128/JCM.02927-20"
"30249697","Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling","Doan TN, Cao P, Emeto TI, McCaw JM, McBryde ES.","Antimicrob Agents Chemother. 2018 Nov 26;62(12):e01487-18. doi: 10.1128/AAC.01487-18. Print 2018 Dec.","Doan TN","Antimicrob Agents Chemother","2018","2018/09/26","PMC6256788","","10.1128/AAC.01487-18"
"34216736","Comparison of the in vitro activity of linezolid, tedizolid, sutezolid, and delpazolid against rapidly growing mycobacteria isolated in Beijing, China","Wen S, Gao X, Zhao W, Huo F, Jiang G, Dong L, Zhao L, Wang F, Yu X, Huang H.","Int J Infect Dis. 2021 Aug;109:253-260. doi: 10.1016/j.ijid.2021.06.055. Epub 2021 Jul 1.","Wen S","Int J Infect Dis","2021","2021/07/03","","","10.1016/j.ijid.2021.06.055"
"31036687","Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay","Converse PJ, Almeida DV, Tyagi S, Xu J, Nuermberger EL.","Antimicrob Agents Chemother. 2019 Jun 24;63(7):e00426-19. doi: 10.1128/AAC.00426-19. Print 2019 Jul.","Converse PJ","Antimicrob Agents Chemother","2019","2019/05/01","PMC6591589","","10.1128/AAC.00426-19"
"30215242","Erratum: Delamanid, Bedaquiline, and Linezolid Minimum Inhibitory Concentration Distributions and Resistance-related Gene Mutations in Multidrug-resistant and Extensively Drug-resistant Tuberculosis in Korea","","Ann Lab Med. 2019 Jan;39(1):113. doi: 10.3343/alm.2019.39.1.113.","","Ann Lab Med","2019","2018/09/15","PMC6143465","","10.3343/alm.2019.39.1.113"
"32210596","Comparison of in vitro Susceptibility of Mycobacteria Against PA-824 to Identify Key Residues of Ddn, the Deazoflavin-Dependent Nitroreductase from Mycobacterium tuberculosis","Zhang F, Li S, Wen S, Zhang T, Shang Y, Huo F, Xue Y, Li L, Pang Y.","Infect Drug Resist. 2020 Mar 11;13:815-822. doi: 10.2147/IDR.S240716. eCollection 2020.","Zhang F","Infect Drug Resist","2020","2020/03/27","PMC7073430","","10.2147/IDR.S240716"
"33614576","Linezolid Resistance in Enterococcus faecalis Associated With Urinary Tract Infections of Patients in a Tertiary Hospitals in China: Resistance Mechanisms, Virulence, and Risk Factors","Ma X, Zhang F, Bai B, Lin Z, Xu G, Chen Z, Sun X, Zheng J, Deng Q, Yu Z.","Front Public Health. 2021 Feb 5;9:570650. doi: 10.3389/fpubh.2021.570650. eCollection 2021.","Ma X","Front Public Health","2021","2021/02/22","PMC7893085","","10.3389/fpubh.2021.570650"
"36550469","Hyperammonemia in a septic patient with Ureaplasma parvum arthritis: a case report","Pan X, Xu J, Pan L, Wang C, Qiu J, Huang X, Yan C, Mao M.","BMC Infect Dis. 2022 Dec 22;22(1):958. doi: 10.1186/s12879-022-07953-8.","Pan X","BMC Infect Dis","2022","2022/12/22","PMC9783457","","10.1186/s12879-022-07953-8"
"34851179","Strong Increase in Moxifloxacin Resistance Rate among Multidrug-Resistant Mycobacterium tuberculosis Isolates in China, 2007 to 2013","Xia H, Zheng Y, Liu D, Wang S, He W, Zhao B, Song Y, Ou X, Zhou Y, van den Hof S, Cobelens F, Zhao Y.","Microbiol Spectr. 2021 Dec 22;9(3):e0040921. doi: 10.1128/Spectrum.00409-21. Epub 2021 Dec 1.","Xia H","Microbiol Spectr","2021","2021/12/01","PMC8635133","","10.1128/Spectrum.00409-21"
"31622366","Switching to bedaquiline for treatment of rifampicin-resistant tuberculosis in South Africa: A retrospective cohort analysis","Bouton TC, de Vos M, Ragan EJ, White LF, Van Zyl L, Theron D, Horsburgh CR, Warren RM, Jacobson KR.","PLoS One. 2019 Oct 17;14(10):e0223308. doi: 10.1371/journal.pone.0223308. eCollection 2019.","Bouton TC","PLoS One","2019","2019/10/18","PMC6797261","","10.1371/journal.pone.0223308"
"29258954","Supramolecular strategy for reducing the cardiotoxicity of bedaquiline without compromising its antimycobacterial efficacy","Kuok KI, In Ng PC, Ji X, Wang C, Yew WW, Chan DPC, Zheng J, Lee SMY, Wang R.","Food Chem Toxicol. 2018 Sep;119:425-429. doi: 10.1016/j.fct.2017.12.022. Epub 2017 Dec 16.","Kuok KI","Food Chem Toxicol","2018","2017/12/21","","","10.1016/j.fct.2017.12.022"
"31141643","Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment","de Vos M, Ley SD, Wiggins KB, Derendinger B, Dippenaar A, Grobbelaar M, Reuter A, Dolby T, Burns S, Schito M, Engelthaler DM, Metcalfe J, Theron G, van Rie A, Posey J, Warren R, Cox H.","N Engl J Med. 2019 May 30;380(22):2178-2180. doi: 10.1056/NEJMc1815121.","de Vos M","N Engl J Med","2019","2019/05/30","PMC6518951","","10.1056/NEJMc1815121"
"31717322","Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation","Iglesias E, Bayona-Bafaluy MP, Pesini A, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Montoya J, Ruiz-Pesini E.","Cells. 2019 Nov 8;8(11):1407. doi: 10.3390/cells8111407.","Iglesias E","Cells","2019","2019/11/14","PMC6912777","","10.3390/cells8111407"
"31927919","Effect of Natural Phenolics on Pharmacokinetic Modulation of Bedaquiline in Rat to Assess the Likelihood of Potential Food-Drug Interaction","Kotwal P, Dogra A, Sharma A, Bhatt S, Gour A, Sharma S, Wazir P, Singh PP, Kumar A, Nandi U.","J Agric Food Chem. 2020 Feb 5;68(5):1257-1265. doi: 10.1021/acs.jafc.9b06529. Epub 2020 Jan 24.","Kotwal P","J Agric Food Chem","2020","2020/01/14","","","10.1021/acs.jafc.9b06529"
"33017766","Role of oxidative stress in clofazimine-induced cardiac dysfunction in a zebrafish model","Ng PCI, Chan JYW, Leung RKK, Li J, Ren Z, Chan AWH, Xu Y, Lee SS, Wang R, Ji X, Zheng J, Chan DPC, Yew WW, Lee SMY.","Biomed Pharmacother. 2020 Dec;132:110749. doi: 10.1016/j.biopha.2020.110749. Epub 2020 Oct 2.","Ng PCI","Biomed Pharmacother","2020","2020/10/05","","","10.1016/j.biopha.2020.110749"
"34108590","Nationwide surveillance of antimicrobial susceptibility of 509 rapidly growing mycobacteria strains isolated from clinical specimens in Japan","Kamada K, Yoshida A, Iguchi S, Arai Y, Uzawa Y, Konno S, Shimojima M, Kikuchi K.","Sci Rep. 2021 Jun 9;11(1):12208. doi: 10.1038/s41598-021-91757-4.","Kamada K","Sci Rep","2021","2021/06/10","PMC8190260","","10.1038/s41598-021-91757-4"
"30016255","Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012","Williams DL, Araujo S, Stryjewska BM, Scollard D.","Emerg Infect Dis. 2018 Aug;24(8):1584-1585. doi: 10.3201/eid2408.180033.","Williams DL","Emerg Infect Dis","2018","2018/07/18","PMC6056125","","10.3201/eid2408.180033"
"33356838","Tissue specific diversification, virulence and immune response to Mycobacterium bovis BCG in a patient with an IFN-γ R1 deficiency","Korol CB, Shallom SJ, Arora K, Boshoff HI, Freeman AF, King A, Agrawal S, Daugherty SC, Jancel T, Kabat J, Ganesan S, Torrero MN, Sampaio EP, Barry C 3rd, Holland SM, Tettelin H, Rosenzweig SD, Zelazny AM.","Virulence. 2020 Dec;11(1):1656-1673. doi: 10.1080/21505594.2020.1848108.","Korol CB","Virulence","2020","2020/12/28","PMC7781554","","10.1080/21505594.2020.1848108"
"29130630","A structure-based strategy toward the development of novel candidates for antimycobacterial activity: Synthesis, biological evaluation, and docking study","Li L, Jin Y, Wang B, Yang Z, Liu M, Guo H, Zhang J, Lu Y.","Chem Biol Drug Des. 2018 Mar;91(3):769-780. doi: 10.1111/cbdd.13142. Epub 2017 Dec 7.","Li L","Chem Biol Drug Des","2018","2017/11/14","","","10.1111/cbdd.13142"
"32618257","Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis","Ngabonziza JCS, Van Deun A, Migambi P, Niyigena EB, Dusabe T, Habimana YM, Ushizimpumu B, Mulders W, Decroo T, Affolabi D, Supply P, de Jong BC, Rigouts L.","Am J Trop Med Hyg. 2020 Oct;103(4):1443-1446. doi: 10.4269/ajtmh.20-0201.","Ngabonziza JCS","Am J Trop Med Hyg","2020","2020/07/04","PMC7543851","","10.4269/ajtmh.20-0201"
"29475890","Mutation in luxR Family Transcriptional Regulator Rv0890c Is Not a Marker of Linezolid Resistance","Zimenkov D.","Antimicrob Agents Chemother. 2018 Feb 23;62(3):e02087-17. doi: 10.1128/AAC.02087-17. Print 2018 Mar.","Zimenkov D","Antimicrob Agents Chemother","2018","2018/02/25","PMC5826140","","10.1128/AAC.02087-17"
